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Diphthamide, the target of diphtheria toxin, is a unique posttranslational 
modification on eukaryotic and archaeal translation elongation factor 2 (EF2). The 
proposed biosynthesis of diphthamide involves three steps. The first step is the 
formation of a C-C bond between the histidine residue and the 3-amino-3-
carboxylpropyl group of S-adenosylmethionine (SAM), which is catalyzed by four 
enzymes Dph1-Dph4 in eukaryotic or only one enzyme Dph2 in archaea; the second 
step is the trimethylation of the amino group by Dph5; and the last step is an ATP 
depended amidation of the carboxyl group by an unknown enzyme.  
We have recently found that in an archaeal species Pyrococcus horikoshii (P. 
horikoshii), the first step uses an S-adenosyl-L-methionine (SAM)-dependent [4Fe–
4S] enzyme, PhDph2, to catalyze the formation of a C–C bond. Crystal structure 
shows that PhDph2 is a homodimer and each monomer contains three conserved 
cysteine residues that can bind a [4Fe–4S] cluster. In the reduced state, the [4Fe–4S] 
cluster can provide one electron to reductively cleave the bound SAM molecule. 
However, different from classical radical SAM enzymes, biochemical evidence 
suggests that a 3-amino-3-carboxypropyl radical is generated in PhDph2. Further 
evidence shows that the 3-amino-3-carboxypropyl radical does not undergo hydrogen 
abstraction reaction, which was observed for the deoxyadenosyl radical in classical 
radical SAM enzymes. Instead, the 3-amino-3-carboxypropyl radical is added to the 
  
imidazole ring in the pathway towards the formation of the product. Furthermore, the 
chemistry requires only one [4Fe–4S] cluster to be present in the PhDph2 dimer.  
The successful reconstitution of the first step of diphthamide biosynthesis 
provides the substrate for the second step. We then reconstituted the second step using 
P. horikoshii PhDph5 in vitro. The results demonstrate that PhDph5 is sufficient to 
catalyze the mono-, di-, and trimethylation of PhEF2. Interestingly, the trimethylated 
product from the PhDph5-catalyzed reaction can easily eliminate the trimethylamino 
group even in the very mild reaction conditions. This unexpected finding on the 
diphthamide biosynthesis pathway may suggest that the last amidation step occurs 
very quickly in cells to avoid the elimination reaction or the amidation step occurs 
before the trimethylation step. 
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1 
CHAPTER 1 
BACKGROUND AND INTRODUCTION 
1.1.Posttranslational Modification 
The proteome is encoded by the genome in each organism. The human 
encoding genome contains more than 30, 000 genes, whereas the human proteome 
consists of more than 1000, 000 molecular species of proteins(1). There are two ways 
to expand the preteomes:  mRNA splicing (2, 3) and protein posttranslational 
modifications (PTMs).  
PTMs play essential roles in the cellular functions and regulations. It accounts 
for the diversity of proteins beyond encoding by genome by changing the physical and 
chemical properties, conformations, stabilities and locations of the protein in cell. 
Histone PTMs such as methylation and demethylation, acetylation and deacetylation 
can regulate transcription by changing the chromatin structure (4-6). Some PTMs, 
such as protein phosphorylation, are related to signal transduction. For example, 
phosphorylation by tyrosine kinases and dephosphorylation by phosphatases of 
tyrosine transduce signals in the insulin/IGF-1 signaling pathway upon ligand binding 
to the receptor(7). Protein PTMs usually occur in two  ways (1): covalent chemical 
modifications of a protein after its translation from mRNAs on the side chains of the 
amino acid residues or chemical cleavage of the peptide backbones.  A protein can be 
modified by covalent additions of some chemical groups, usually electrophilic 
fragments, to one or more side chains in a protein precursor. 15 out of 20 common 
proteinogenic amino acids have side chains, usually a nucleophile, that can undergo 
such diverse modification (Table 1.1)(1). The most commonly identified PTMs 
include phosphorylation, methylation, acetylation, glycosylation, sulfation, prenylation 
and ubiquitination. Some PTMs are covalent cleavage of peptide backbones in 
proteins. The most common example for this kind of PTM involves insulin. Insulin is 
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translated as a single-chain inactive prohormone that turns to the active two-chain 
form of insulin by removal of the central part of the proinsulin and subsequent rejoint 
of the terminals with a disulfide bond (8). 
Table 1.1.  Posttranslational modifications at amino acid side chains1(1) 
aa Residue posttranslational modification Example 
Asp phosphorylation  isomerization to isoAsp protein tyrosine phosphatases 
Glu 
methylation  
carboxylation  
polyglycination  
polyglutamylation  
 chemotaxis receptor proteins 
 Gla residues in blood 
coagulation 
 tubulin 
 tubulin 
Ser 
phosphorylation 
O-glycosylation 
phosphopantetheinylation 
autocleavages  
serine kinases and phosphatases 
 notch O-glycosylation 
 fatty acid synthase 
 pyruvamidyl enzyme formation 
Thr phosphorylation  O-glycosylation threonine kinases/phosphatases 
Tyr 
phosphorylation  
sulfation  
ortho-nitration  
TOPA quinone  
 tyrosine kinases/phosphatases 
 CCR5 receptor maturation 
 inflammatory responses 
 amine oxidase maturation 
His 
phosphorylation 
aminocarboxypropylation  
N-methylation  
sensor protein kinases  
diphthamide formation 
methyl CoM reductase 
Lys 
N-methylation  
N-acylation  
C-hydroxylation  
histone methylation 
histone acetylation 
collagen maturation 
 
                                                 
1 This table is adapted from C.T. Walsh et al. Protein Posttranslational Modifications: the Chemistry of 
Proteome Diversifications Angew. Chem. Int. Ed. 2005, 44, 7342 -7372 
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Table 1.1. Continued 
Cys 
S-hydroxylation (S-OH) 
disulfide bond formation 
phosphorylation  
S-acylation 
S-prenylation 
protein splicing 
 sulfenate intermediates 
 protein in oxidizing 
environments 
 PTPases 
 Ras 
 Ras 
 intein excisions 
Met oxidation to sulfoxide   Met sulfoxide reductase 
Arg N-methylation  N-ADP-ribosylation  
 histones 
 GSa 
Asn 
N-glycosylation  
N-ADP-ribosylation  
protein splicing  
N-glycoproteins 
 eEF-2 
 intein excision step 
Gln transglutamination  protein cross-linking 
Trp C-mannosylation  plasma-membrane proteins 
Pro C-hydroxylation  collagen; HIF-1a 
Gly C-hydroxylation  C-terminal amide formation 
 
PTMs, like other biological reactions, require enzymes and sometimes co-
substrates. It is worth mentioning that in most cases, PTMs are catalyzed by enzymes 
and more than 5% of the human geonome (between 1000 to 2000 genes) may encode 
enzymes dedicated to protein posttranslational modifications. The most common co-
substrates involved in posttranslational modifications are small molecules such as 
ATP/GTP for phosphorylation, NAD for ADP-ribosylation, S-adenosyl-L-methionine 
(SAM) for methyl transfer and PAPS (phosphoadenosine phosphosulfate) for sulfuryl 
group transfer, as shown in Figure 1.1. However, some posttranslational modification 
4 
enzymes use small proteins as donors of the electrophilic fragments. For example, in 
the ubiquitylation of proteins, ubiquitin, a 76-residue protein, is used as a co-substrate. 
 
 
Figure 1.1. Structures of small molecular co-substrate in PTMs. 
 
PTMs can be studied by characterizing the modified products with various 
techniques. The classic technique to detect the PTMs is thin layer chromatography 
(TLC) or high performance liquid chromatography (HPLC) after Edman degradation 
of the modified proteins. Another technique is autoradiography that uses radio-labeled 
co-substrates to label the modified proteins for detection.  Two-dimensional gel 
electrophoresis detects the subtle difference exhibited by the modified and unmodified 
proteins in gel electrophoresis. Since most PTMs can result in a change in mass of 
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modified protein, mass spectrometry is routinely used now to detect PTMs(9). The 
changes in mass in some common PTMs are shown in table 1.2.   
Table 1.2. The mass changes in some common PTMs. 
 
1.2.Diphthamide 
Diphtheria was a serious disease with fatality rate up to 20% before the 
introduction of vaccination. The disease is caused by a gram-positive bacterium, 
Corynebacterium diphtheriae. C. diphtheriae kills the host cells by secreting a toxin 
called diphtheria toxin (DT), which contains two fragments A and B held together by a 
disulfide bond. Fragment A is a catalytic domain. Fragment B is a recognition subunit 
and can get access to the host cell by binding to the plasma membrane. Once DT is in 
the endosome, fragment A will be released from fragment B into the cytosol or 
PTMs Nominal mass shift (Da)
Phosphorylation 80
Glycosylation
O/N-linked 203, >800
Ubiquitination >1000
Sumoylation >1000
Nitration, nTyr 45
Nitrosylation, nSer, nCys 29
Methylation 14
Acetylation 42
Sulfation, sTyr 80
Deamidation 1
Farnesyl 204
Myristoyl 210
Palmitoyl 238
Disulfide bond -2
Alkylation, aCys 57
Oxidation 16
diphthamide 1st step 101
diphthamide 2nd step 143
diphthamide 3rd step 115
6 
intracellular fluid of the host cell and catalyze the ADP-ribosylation of the eukaryotic 
elongation factor 2(eEF-2) on a specific modified histidine residue(10, 11). The 
specific modified histidine residue is a unique protein posttranslational modification 
on eEF2, which is named diphthamide , since it is the target of diphtheria toxin(12).  
The eEF2 is a GTPase that catalyzes the translocation of the peptidyl-tRNA and 
mRNA from the ribosome A site to the P site, which is essential for protein 
biosynthesis. The ADP-ribosylation of diphthamide by DT on eEF-2 inhibits the 
protein synthesis and leads to host cell death. The diphthamide residue is also a target 
of Pseudomonas exotoxin A (ETA), which is similar to diphtheria toxin (Figure 
1.2)(13, 14). 
 
 
Figure 1.2. The proposed diphthamide biosynthesis pathway and ADP ribosylation 
ofdiphthamide by bacterial toxins. DT: Diphtheria toxin; ETA: Pseudomonas exotoxin 
A 
 
Diphthamide is conserved in all eukaryotes and archaea. Although it has been 
identified for more than three decades, the biosynthesis and biophysical function of 
diphthamide remain unclear (15, 16). A recent report showed that diphthamide helps 
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to prevent -1 frame shift in ribosomal protein synthesis(16). However, no obvious 
phenotype can be identified in yeast that lacks diphthamide modification (12, 17, 18). 
Genetic studies over the past three decades revealed that five genes, dph1, dph2, dph3, 
dph4, and dph5, are required for the biosynthesis of diphthamide (12, 18-24). The 
biosynthesis pathway of diphthamide was proposed based on these studies(25). The 
first step of the biosynthesis is the transfer of 3′-amino-3′-carboxypropyl group from 
S-adenosyl-L-methionine (SAM) (26) to the C-2 position of the imidazole ring of the 
His residue in eEF-2 (His715 in mammalian eEF-2, His699 in yeast eEF-2 and His600 
in archaea Pyrococcus horikossii).  It is catalyzed by four proteins, Dph1, Dph2, 
Dph3, and Dph4 in eukaryote and only one protein Dph2 was found by BLAST search 
in archaeal species. The second step is trimethylation of the amino group catalyzed by 
Dph5. The last step is ATP-dependent amidation of the carboxyl group catalyzed by 
unknown enzymes. The first step is particularly intriguing, because carbon-carbon 
bond formation is rare in posttranslational modification and in the diphthamide case it 
involves the poorly nucleophillic C-2 position of the imidazole ring. 
 Interesting questions can be asked here: How can this reaction happen?  Why 
does it need four enzymes in the eukaryotic diphthamide biosynthesis? What are the 
functions of these enzymes? 
Little is known about the four enzymes to date. Bioinformatics suggests that 
Dph1 and Dph2 are about 20% homologous. Dph1, originally named ovca1since its 
deletion was found in about 80% of ovarian tumors, was found to be a tumor 
suppressor gene in human before it was identified as one of the genes involved in 
diphthamide biosynthesis (23, 27, 28).  Loss of a dph1 gene was also observed in other 
types of cancers, such as breast, lung, and brain malignancies (29-32). Homozygous 
dph1 knockout (dph1-/-) mice die before or at birth, while heterozygous dph1 mice 
(dph1+/-) survived but were prone to develop tumors later in their life(23, 28) . 
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Dph3 and Dph4 both contain a putative CSL zinc finger, which has four Cys residues 
to coordinate Zn2+ (33) and the last Cys residue is followed by a Ser and a Leu residue 
(hence the name CSL zinc finger). However, no function has been assigned to CSL 
zinc fingers yet.  Dph3 is a small protein (~80 aa) that essentially just contains the 
CSL zinc finger, while Dph4 contains a J domain in addition to the zinc finger 
domain. The J domain is the 70-residue signature domain of the Hsp40 chaperon 
family of proteins (such as DnaJ in E. coli) and is present in many other proteins(34) .   
Dph3 is required not only for diphthamide biosynthesis, but also for synthesis of 5-
methoxycarbonylmethyl (mcm5) and 5-carbamoylmethyl (ncm5) groups present on 
uridines at the wobble position of tRNA(35). Dph4 mutations were found in cancers. 
Why does Dph1 deficiency promote tumor formation?  Is there any inherent 
connection between diphthamide and tumor suppression? In other words, does the 
deficiency of diphthamide on eEF-2 promote tumor formation in Dph1/Dph4 deficient 
cells?   What is the biological function of diphthamide?  These questions remain 
unanswered. To address these questions, we have to understand better how 
diphthamide is synthesized and how the biosynthesis is regulated, which is the focus 
of my thesis. 
Originally, our lab tried to reconstitute the biosynthesis of diphthamide in 
yeast. But the proteins required for the biosynthesis were difficult to express. The 
expression levels were too low to get enough protein for the reconstitution. Later, we 
decided to study the diphthamide biosynthesis in a thermorphilic archaeal species, 
Pyrococuss horikossii. As mentioned above, among the four proteins required for the 
first step of diphthamide biosynthesis, only one is present in P. horikoshii. This 
protein was named Dph2. Here we refer it to PhDph2. We first want to know whether 
one enzyme, PhDph2, is enough to catalyze the modification. If it is enough, what is 
the reaction mechanism? 
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As mentioned in the last section, the first and second steps of diphthamide 
biosynthesis need SAM as co-substrate. Therefore, the enzymes utilized in 
diphthamide biosynthesis were expected to exhibit common characteristics of SAM-
dependent enzymes. However, we found PhDph2 is different from all the other SAM-
dependent enzymes and my thesis work will show that it mediates diphthamide 
biosynthesis via a novel radical mechanism. To better understand the diphthamide 
biosynthesis, it is necessary to introduce the SAM-dependent enzyme family in terms 
of their characteristics and their reaction mechanisms.  
 
1.3. SAM-dependent Enzymes 
S-adenosyl-L-methionine (SAM or AdoMet) is the second most widely used 
enzyme substrate after ATP (36) and involved in many essential biochemical 
processes (37). SAM-dependent enzymes are divided into two catalogues based on the 
reaction mechanism: the general SAM-dependent enzymes, which catalyze the SAM-
related reaction by nucleophilic mechanism, and the radical SAM superfamily 
enzymes.  
1.3.1. General SAM-dependent enzymes  
SAM is the major methyl donor for various methylation reactions in living 
organisms, such as methylation of tRNA, histone, hormones and phospholipids. In 
these reactions, a nucleophile (:Nu) attacks the methyl carbon to heterolyticly cleave 
the sulfur-carbon (methyl) bond via a SN2 mechanism, which results in the transfer of 
methyl group to the nucleophile to form Nu-CH3 and the release of S-
adenosylhomocysteine (SAH), as shown in Figure1.3.  
SAM is also used as a source of ribosyl groups. For example, in the  
 penultimate step of the biosynthetic pathway of queuosine, a hypermodified tRNA 
nucleoside (38-41), SAM is cleaved by enzyme QueA to form the 2,3-epoxy-4,5-
10 
dihydroxycyclopentane ring of the Q precursor epoxyqueosine (oQ), which reacts with 
tRNA to form  tRNA-oQ. The mechanism is shown below (Figure1.4).  
 
 
Figure 1.3. Reaction mechanism of SAM as a methyl group donor. 
 
  
Figure 1.4. Reaction mechanism of SAM as ribosyl group donor. 
 
SAM used as an aminopropyl group donor was also found in several 
biosynthetic pathways, such as the biosynthesis of a β-lactam antibiotic, 
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norcadicine(42), the synthesis of betaine lipid(43, 44), the synthesis of spermidine(45) 
and the synthesis of wybutosine in certain tRNA(46) (Figure 1.5) (42, 44). These 
reactions are believed to occur via an SN2-like mechanism, with either a hydroxyl or an 
amino group as the nucleophile, except for the reaction in wybutosine biosynthesis 
(Figure 1.5) (36). In fact, SAM can be regarded as a positively charged sulfur atom 
with three different groups attached: a methyl group, a 5′-deoxyadenosyl group and a 
3′-amino-3′-carboxypropyl group. The positively charged sulfur makes the adjacent 
carbon centers somewhat electrophilic. These carbon centers are susceptible to the 
attack by nucleophiles, which drives this type of SAM-dependent enzymatic reactions 
to occur. 
 
 
Figure 1.5. Known enzymatic reactions that involve the transfer of the substituted 
aminopropyl group of SAM or decarboxy-SAM to different acceptor molecules. The 
reaction in wybutosine biosynthesis is similar to the first step of diphthamide 
biosynthesis and use a carbon nucleophile. 
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1.3.2 Radical SAM Superfamily Enzymes  
Radical S-adenosyl-L-methionine (SAM) enzymes are of ancient origins. To 
date, more than 2800 proteins are found by sequence analysis to belong to the radical 
SAM superfamily, which share a common amino acid sequence motif, CXXXCXXC 
near the N terminus (Table 1.3). However, recent studies have revealed some 
variations, such as the CXXCXXXXC motif at C terminus in ThiC, an enzyme 
involved in thiamine diphosphate biosynthesis in prokaryotes (47-50),  and the 
CXXXXCXXC motif in Elp3(51) and hmdB(52). Therefore, the radical SAM 
superfamily may be significantly larger than previously imagined, and it is no longer 
justified to characterize the radical family simply based on the presence of a 
CXXXCXXC motif in the N-terminal half of a protein sequence. We should also be 
open to new discoveries that may expand the radical SAM family, as we have learned 
through this thesis work. Some members of radical SAM superfamily enzymes are 
listed in Table 1.4 together with the biological functions of the enzymes(53). 
Table 1.3. Common amino acid sequence motif in classic radical SAM enzymes 
 
 
Since PhDph2 is a radical SAM enzyme, as shown in later chapters of my 
thesis, the radical SAM enzyme family is the focus of the following discussion, in 
terms of the binding mode of SAM, the structural motif of enzymes and the reaction 
mechanism. 
LAM …CSMYCRHC… 
PFL activase …CLMRCLYC… 
ARR …CVHECPGC… 
BioB …CPEDCYKC… 
LipA …CTRRCPFC… 
common motif   CXXXCXXC 
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Table 1.4. Classic radical SAM enzymes and their function.2 
Enzymes                                  Function                                 Refference                         
LAM                      Lysine 2,3aminomutase                        Ruzicka et al., 2000(54) 
BlsG                      Arginine 2,3-aminomutase                    Cone et al., 2003(55) 
Eam                       Glutamate 2,3-aminomutase                  Ruzicka & Frey, 2007(56) 
SplB                      Spore photoproduct lyase                       Rebeil et al., 1998(57) 
DesII                     Desosamine biosynthesis                       Trefzer et al.,1999(58) 
PFL activase         Glycyl radicalization                              Wong et al., 1993(59) 
ARR activase        Glycyl radicalization                              Eliasson et al., 1990(60) 
BioB                      Biotin synthase                                       Duin et al., 1997(61) 
LipA                      Lipoyl synthase                                      Reed & Cronan, 1993(62) 
HemN                   Coproporphyrinogen III oxidase            Akhtar, 1994(63) 
MoaA                    Molybdopterin biosynthesis                   Rieder et al., 1998(64) 
MiaB                     Methylthiolation of tRNA                      Esberg et al., 1999(65) 
TYW1                   Wybusine biosynthesis in tRNAPhe       Noma et al.., 2006(66) 
ThiH                      Biogenesis of thiazole in thiamine          Begley et al., 1999(67) 
NifB                       Nitrogenase FeMoCo maturation           Allen et al., 1995(68) 
AtsB                       Formylglycine formation in                    Fang et al., 2004(69) 
CloN6                    Clorobicin biosynthesis                           Westrich et al., 2003(70) 
Nclk                       Cdk5 activator binding                            Ching et al., 2000(71) 
AviX12                  Epimerization in Avilamycin A               Boll et al., 2006(72) 
Elp3                       Elongator complex function                Paraskevopoulou, 2006(73) 
PcfB                      Maturation of propionicin F                      Brede et al., 2004(74) 
 
1.3.2-1Binding mode of SAM in radical SAM enzymes 
SAM binds to one iron of [4Fe-4S] cluster of radical SAM enzymes via the α-
amino and α-carboxylate groups of SAM. Radical SAM enzymes use a [4Fe-4S] 
cluster as the reactive center. The three irons in the [4Fe-4S] cluster are coordinated 
with three cysteine residues in a CXXXCXXC motif, while the fourth iron is non-
coordinated but locked to a certain position in the cubane structure of the [4Fe-4S] 
cluster. It is this iron that coordinates with the coming SAM molecule. How does 
SAM bind to the fourth iron?  Electron nuclear double resonance (ENDOR) 
spectroscopy and the X-ray crystal structure make it clear.  15N and 17O- ENDOR 
                                                 
2 This table is adapted from P. A. Frey et al The radical SAM superfamily Critical Reviews in 
Biochemistry and Molecular Biology, 43: 63-88, 2008 
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spectroscopy on PFL activase (75) implicated that the amino and carboxylate groups 
of the methionyl moiety in SAM are ligands to the non-coordinated iron (Figure 
1.6)(76). The x-ray crystal structure of the complex of LAM with PLP, SeSAM, and 
lysine shows the non-coordinated iron of the [4Fe–4S] cluster to be the nearest 
neighbor to selenium in SeSAM at a distance of 3.2 Å.  Therefore, the fourth iron is 
chelated to the α-amino and α-carboxylate groups of SAM. 
 
 
Figure 1.6. Binding mode of SAM in radical SAM enzyme3 the three irons in the 
[4Fe-4S] cluster are coordinated with three cysteine residues in a CXXXCXXC motif, 
while the fourth iron is chelated to the α-amino and α-carboxylate groups of SAM. 
 
1.3.2-2The structural characteristics of radical SAM enzymes  
Only a few radical SAM superfamily enzymes have been structurally 
characterized. All of the solved structures contain a complete (βα) 8 barrel (BioB and 
HydE) (Figure 1.7) or a partial incomplete (βα) 6 barrel (77-83). 
 The crystal structures of the radical SAM enzymes shed light on the radical 
cleavage reaction at the active site (84). Firstly, in all the crystal structures the [4Fe-
                                                 
3 This Figure is from Squire J Booker and Tyler L Grove Mechanistic and functional versatility of 
radical SAM enzymes F1000 Biol Report 2010, 2:52 
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4S] cluster is located at one end of the barrel with the non-coordinated iron oriented 
toward the center of the barrel (Figure1.7). This unique iron is coordinated by the 
amino and carboxyl groups of SAM, which partially seals off the cluster from solvent 
to protect the oxygen-sensitive cluster from degradation. Secondly, SAM is 
surrounded by a number of conserved residues and has various non-covalent 
interactions with them, such as electrostatic, H-bonding, hydrophobic, and π-stacking 
interactions. This apparently takes tight control of SAM binding for optimal catalytic 
function in the active site.  Finally, several of the radical SAM crystal structures reveal 
the presence of loops (Figure1.7) that may undergo conformational changes upon 
substrate binding to help seal off the active sites for optimal radical reaction (78).  
 
 
Figure 1.7. 4X-ray crystal structures of Biotin synthase (BioB, left) with both SAM 
and dethiobiotin bound and HydE (right) contain a complete TIM (βα)8 barrel. 
 
 
                                                 
4 Reuse Figure with permission from Duschene, K.S., Veneziano, S.E., Silver, S.C., Broderick, J.B. 
Current Opinion in Chemical Biology  2009; 13(1):74-83 Copyright 2009, Elsevier 
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1.3.2-3 The reaction mechanisms in some radical SAM enzymes  
In addition to crystal structure studies mentioned above, spectroscopic and 
biochemical characterization have also been employed to study the reaction 
mechanisms catalyzed by radical SAM enzymes. Their [4Fe-4S]2+ clusters, can be 
reduced by dithionite in vitro to the reduced form [4Fe-4S]1+, which transfers one 
electron to SAM. Subsequently SAM is cleaved to give the 5-deoxyadenosyl radical 
and methionine (Figure 1.8).  
 
 
Figure 1.8. The mechanism of SAM cleavage by classic radical SAM enzymes. 
 
Lysine 2, 3-aminomutase  
 
 
Figure 1.9. The interconversion of L- lysine and L-β-lysine catalyzed by 2, 3- 
aminomutase (LAM). 
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The most extensively studied radical SAM enzyme is lysine 2, 3-aminomutase 
(LAM). This enzyme catalyzes the first step in the metabolism of lysine to acetate, the 
interconversion of L-lysine and L-β-lysine (Figure 1.9) (85, 86). LAM uses pyridoxal 
5′-phosphate (PLP) as a cofactor and is sensitive to air. The addition of ferrous iron 
and PLP increased its activity. EPR analysis indicated the presence of a [4Fe–4S] 
cluster (87, 88).  And most importantly, LAM activity absolutely depends on 
dithionite and S-adenosyl-L-methionine (SAM). In fact, the interconversion of L-
lysine and L-β-lysine basically resembles the B12-dependent rearrangement that has 
been known to follow a radical mechanism. However, instead of using 
adenosylcobalamin as a substrate, the interconversion of L-lysine and L-β-lysine 
catalyzed by LAM uses SAM. In addition, the traditional role of PLP in catalysis was 
to stabilize the amino acid carbanions (89), however, its role in the LAM-catalyzed 
reaction could not be explained, which made it more interesting to study the 
rearrangement mechanism involving SAM and PLP in LAM-catalyzed reaction. And 
SAM was later found to be cleaved to form 5′-deoxyadenosyl radical that abstracts 
hydrogen from the substrate lysine (90, 91). The mechanism of hydrogen and amino 
transfer is shown in Figure 1.10.  
Three of the four radical intermediates in the proposed mechanism have been 
characterized by electron paramagnetic resonance (EPR) spectroscopy and rapid mix-
quench EPR(92) in the presence of natural substrate, substrate analogue, or cofactor 
analogue. Product radical 3 (Figure 1.10) is the dominant radical in the steady state 
and the only one that is stable enough to be detected by EPR spectroscopy when L-
lysine is the substrate (93-96).  Radical stability can be attributed to delocalization of 
the unpaired electron by the carboxyl group. Radical 1 was identified and 
characterized by using substrate analogue, 4-thia-L-lysine, which resulted in the most 
stable radical intermediate under steady state conditions thanks to the adjacent 4-thia 
18 
group(97, 98).  
 
 
Figure 1.10. Radical reaction mechanism of Lysine 2, 3-aminomutase (LAM). Three 
radical intermediates (labeled 1, 2 and 3) are generated in the reaction. The radical 3 is 
the dominant radical in the steady state and the only one that is stable enough to be 
detected by EPR spectroscopy when L-lysine is the substrate. SAM serves as a 
coenzyme and is not consumed in the reaction. 
 
By using the same strategy, 5′-deoxyadenosyl radical was identified and 
characterized using an allylic analogue of the SAM, anhydroSAM (anSAM,). An 
allylic radical via reductive cleavage of anSAM (99) (Figure 1.11) was spin 
delocalized and stable enough to be detected by EPR spectroscopy. 
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Figure 1.11.  An allylic analogue of the SAM, anhydroSAM, can be reductively 
cleaved by LAM to generate a stable allylic radical, which can be detected by EPR 
spectroscopy. 
 
Pyruvate Formate-Lyase Activase and Pyruvate Formate-Lyase 
Pyruvate formate-lyase (PFL) catalyzes the reaction of pyruvate with 
coenzyme A to generate formate and acetyl-CoA(100) (Figure 1.12). The reaction is 
reversible with the forward rate at 770 sec-1 and a backward rate at 260 sec-1(100). 
Aerobically purified PFL did not contain any metals or cofactors and was found to 
have no activity; anaerobically purified PFL is active in the presence of another 
enzyme, pyruvate formate-lyase activation enzyme (PFL-activase) (100, 101).  
 
 
Figure 1.12. Pyruvate formate-lyase (PFL) catalyzes the reaction of pyruvate with 
coenzyme A to generate formate and acetyl-CoA 
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radical, 5'-deoxyadenosyl radical, generated by the reductive cleavage of SAM. The 
reaction requires SAM, and a reductant such as 5'-deazaflavin or dithionite or NADPH 
with the flavodoxin/flavodoxin reductase system (101, 102). During the PFL 
activation process, the 5'-deoxyadenosyl radical stereospecifically abstracts the pro-S 
hydrogen of Gly734 to generate the glycyl radical and 5'-deoxyadenosine (103) 
(Figure 1.13.). It was found that SAM serves as co-substrate in this reaction, since one 
equivalent of SAM is homolytically cleaved to generate 5'-deoxyadenosine and 
methionine (104), which is different from its role as a coenzyme in the reaction 
catalyzed by LAM. 
 
 
Figure 1.13. The reaction mechanism of PFL-activase. SAM as co-substrate in this 
reaction was consumed to generate the 5'-deoxyadenosyl radical. This radical abstracts 
the pro-S hydrogen of Gly734 to generate the glycyl radical and 5'-deoxyadenosine. 
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assigned to be on the α-carbon of Gly734 (105). The α-hydrogen on the glycyl radical 
on PFL undergoes free solvent exchange as demonstrated in the EPR experiments 
performed in deuterium oxides (105, 106). The combination of mechanism-based 
inactivation studies and the site-directed mutagenesis showed that the exchange was 
assisted by Cys419 (107, 108). A ping-pong mechanism as shown in Figure1.14 was  
 
 
Figure 1.14. The reaction mechanism of Pyruvate formate-lyase (PFL). In this 
reaction, pyruvate is converted formate and acetyl-CoA 
 
proposed (100). PFL incorporates two cysteine residues, Cys418 and Cys419, at its 
active site. Hydrogen transfers from the Cys419 to the glycyl radical to generate an 
intermediate cysteine-thiyl radical. The thiyl radical on Cys418 transferred from 
Gly
Cys
Cys
734
419
418
SH
SH
H3C C CO2
O
Gly
Cys
Cys
734
419
418
S
SH
H3C C CO2
O
H Gly
Cys
Cys
734
419
418
SH
S
H3C C CO2
O
H
Gly
Cys
Cys
734
419
418
SH
S
H3C C CO2
O
HGly
Cys
Cys
734
419
418
SH
S
H3C C
O
H
CO2
Gly
Cys
Cys
734
419
418
S
S
H3C C
O
H
HCO2
Gly
Cys
Cys
734
419
418
SH
S
H3C C
O
H3C C SCoA
O
CoASH
22 
Cys419 then produces a formyl radical, which abstracts a hydrogen atom fromCys419 
to form formate and regenerate the glycyl radical. Finally, coenzyme A is acetylated 
by the acetyl group transferred from Cys418 (Figure 1.14). 
 
Biotin Synthase 
 
 
Figure 1.15. The biotin biosynthesis pathway. 
 
The biosynthesis of biotin in plants and most bacteria includes four steps each 
catalyzed by one enzyme: BioF (KAPA synthase), BioA (DAPA synthase), BioD 
(dethiobiotin synthase) and BioB (biotin synthase) (109) (Figure 1.15) The convertion 
of dethiobiotin to biotin catalyzed by biotin synthase is the most chemically difficult 
one in the pathway. In this step two unreactive hydrogen atoms at carbon 6 and 9 of 
dethiobiotin are abstracted and a sulfur atom is inserted between these two carbons 
HO SCoA
O O
+ L-Alanine
Pimeloyl CoA
HO
O O
NH2
CH3
KAPA
 KAPA
synthase
DAPA synthase
HO
O NH2
NH2
CH3
DAPA
Dethiobiotin 
   synthase
HO
O HN
NH
CH3
O
6
9
Biotin synthase
Dethiobiotin
HO
H
N O
NH
S
O
Biotin
23 
(Figure 1.16). The reaction requires a SAM and a reducing system consisting of 
flavodoxin, flavodoxin reductase and NADPH (110). 
 
 
Figure 1.16. The interconversion of dethiobiotin to biotin. 
  
The crystal structure of E. coli biotin synthase containing the SAM cofactor 
and the substrate dethiobiotin, is the first crystal structure of the radical SAM enzymes 
that has been determined (78). The protein is homodimeric and each monomer adopts 
an (αβ)8 barrel. SAM, dethiobiotin, a [4Fe-4S] and a [2Fe-2S] cluster were observed in 
the active site. The [4Fe-4S] cluster is coordinated by three highly conserved Cys 
residues (Cys53, Cys57 and Cys 60), While the [2Fe-2S] cluster is coordinated by an 
atypical metal ligand, arginine 260 and three Cys residues (Cys97, Cys128, and 
Cys188) (78). Arg260 is not crucial for the catalysis of biotin synthase as suggested by 
mutagenic studies (111).  
What is the function of the [2Fe-2S]? The [2Fe-2S] was found in the 
aerobically purified biotin synthase. Recent biophysical studies including UV-vis, 
EPR, Mössbauer, and resonance Raman spectroscopies have suggested that the sulfur 
atoms in biotin were derived from the [2Fe-2S] cluster (112-114).  
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Figure 1.17. Mechanism of biotin synthesis. 
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radical, which subsequently attacks a bridging μ-sulfido atom of the [2Fe-2S] cluster 
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the 9- mercaptodethiobiotin intermediate to generate the C-6-centered radical 
intermediate. This radical attacks the sulfur atom of the intermediate to form the 
thiophane ring in biotin with reduction of the coordinated FeIII to FeII. The 
abstraction of the hydrogen atom at C-9 occurs prior to that at C-6, which was proven 
by feeding the cells with 35S labeled 9-mercapto dethiobiotin experiments where 35S 
was transferred into biotin by B. sphaericus, while no labeled biotin was found in the 
same experiment with 35S labeled 6-mercapto dethiobiotin (115).  
 
1.4 Dissertation Statement 
My dissertation investigates diphthamide biosynthesis in an archaea species 
Pyrocuccus horrikoshii. The proposed diphthamide biosynthesis includes three steps: 
the first step is the transfer of 3-amino-3-carboxylpropyl group to an histidine residue 
on Elongation Factor 2 (EF2) catalyzed by four enzymes in eukaryotes and one 
enzyme in archaea; the second step is trimethylation of the amino group and the third 
step is amidation of the carboxyl group. My goal is to reconstitute the diphthamide 
biosynthesis in vitro and investigate the mechanisms with autoradiography, 
spectroscopies (UV-Vis, NMR), MALDI-MS and HPLC techniques. 
In Chapter 2, I will present the biochemical and spectroscopic characterization 
of PhDph2 and the detection of a novel radical generated by reductive cleavage of 
SAM by PhDph2. For the first time, we found that PhDph2 is sensitive to oxygen and 
determined that it contains a [4Fe-4S] cluster with x-ray crystallography, UV-vis, EPR 
and Mössbauer spectroscopy, suggesting that PhDph2 may use a radical mechanism. 
We also tried to detect the radical products with biochemical techniques such as 
autoradiography, MALDI-MS and HPLC. The autoradiography experiment shows that 
in the present of PhEF2, PhDph2 can transfer 3′-amino-3′-carboxypropyl from SAM 
to PhEF2. The MALDI-MS of digested PhEF2 after reaction further confirmed the 
26 
modification on PhEF2. An HPLC assay demonstrated that PhDph2 can cleave SAM 
to form 5′-deoxy-5′-methylthioadenosine (MTA) in the presence of a reductant 
dithionite. Two possible mechanisms of the first step of diphthamide biosynthesis, the 
radical mechanism and the nucleophilic attacking mechanism, were proposed based on 
the SAM cleavage product of MTA. The other product of SAM cleavage, 2′-
aminobutiric acid (ABA), was identified by NMR and also detected by LCMS after 
dansyltion reaction monitored by LCMS. Therefore, PhDph2 is a novel radical SAM 
enzyme and catalyzes the first step of diphthamdie biosynthesis via a 3′-amino-3′-
carboxyl radical through a radical mechanism.   
In Chapter 3, detailed mechanistic studies of the first step of diphthamide 
biosynthesis were presented. We found that 3′-amino-3′-carboxyl radical was added 
directly to the C2 of imidozole ring, instead of abstracting one hydrogen to produce an 
amino acid radical. Furthermore, only one [4Fe-4S] cluster instead of both of the 
clusters in the homodimer is needed to facilitate the enzymatic reaction.  
The last chapter of my dissertation shows the work on the reconstitution of the second 
step of diphthamide biosynthesis. Successful reconstitution of the first step of the 
diphthamide biosynthesis in vitro set stage for the reconstitution of the second step by 
providing the substrate for the second step reaction. We found that PhDph5 is 
sufficient to catalyze the mono-, di- and trimethylation of PhEF2. In addition, the 
trimethylated product can easily eliminate the trimethylamino group even in very mild 
reaction conditions in vitro, which may suggest that the last step of diphthamide 
biosynthesis may occur very fast to prevent the elimination reaction from happening in 
vivo. 
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CHAPTER 2 
 
DIPHTHAMIDE BIOSYNTHESIS REQUIRES AN ORGANIC RADICAL 
GENERATED BY AN IRON-SULPHUR ENZYME∗ 
Abstract 
Archaeal and eukaryotic translation elongation factor 2 contain a unique 
posttranslationally modified histidine residue called “diphthamide”, the target of 
diphtheria toxin. The biosynthesis of diphthamide was proposed to involve three steps, 
with the first step being the formation of a C-C bond between the histidine residue and 
the 3-amino-3-carboxypropyl group of S-adenosyl-L-methionine (SAM). However, 
details of the biosynthesis have remained unknown. In this chapter, I present 
biochemical evidence showing that the first step of diphthamide biosynthesis in the 
archaeon Pyrococcus horikoshii uses a novel iron-sulfur cluster enzyme, Dph2. X-ray 
crystal structure shows that Dph2 is a homodimer and each monomer contains a [4Fe-
4S] cluster. Biochemical data suggest that unlike the enzymes in the radical SAM 
superfamily, Dph2 does not form the canonical 5´-deoxyadenosyl radical. Instead, it 
breaks the Cγ,Met-S bond of SAM and generates a 3′-amino-3′-carboxylpropyl radical. 
This work suggests that Pyrococcus horikoshii Dph2 represents a novel SAM-
dependent [4Fe-4S]-containing enzyme that catalyzes unprecedented chemistry. 
 
 
 
 
 
                                                 
∗ Reproduced in part with permission from Zhang, Y. & Zhu, X. et al.  Nature. 2010, 465, 891-896 
Copyright 2010 Nature Publishing Group. 
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Introduction 
Corynebacterium diphtheriae is a pathogenic bacterium that causes the 
infectious disease diphtheria in humans(1). This bacterium kills host cells by secreting 
a protein factor, diphtheria toxin(2), which catalyzes the ADP-ribosylation of a 
posttranslationally modified histidine residue (Figure 2. 1) in eukaryotic translation 
elongation factor 2 (eEF2).(3) Because this posttranslational modification is the target  
of diphtheria toxin, it was named “diphthamide”. eEF2 is a GTPase required for the 
translocation step of ribosomal protein synthesis.(4) The diphthamide modification 
is conserved in all eukaryotes and archaea and is important for ribosomal protein 
synthesis.(4, 5) Although diphthamide was identified more than three decades ago, its 
biosynthesis has remained an enigma.(6) Five genes required for diphthamide 
biosynthesis were identified in eukaryotes, Dph1, Dph2, Dph3, Dph4, and Dph5,(3, 7-
13) and a biosynthetic pathway has been proposed (Figure 2.1). 
 
 
Figure 2.1. The structure of diphthamide and its proposed biosynthesis pathway. The 
diphthamide residue is the target of bacterial ADP-ribosyltransferases, diphtheria toxin 
and Pseudomonas exotoxin A. 
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The first step of diphthamide biosynthesis is the transfer of the 3′-amino-3′-
carboxypropyl (ACP) group from S-adenosyl-L-methionine (SAM) to the C-2 position 
of the imidazole ring of the target histidine residue in eEF2 and is catalyzed by Dph1-
4 in eukaryotes. This step is followed by a trimethylation, catalyzed by Dph5, and an 
amidation, catalyzed by an unidentified enzyme. The first step is particularly 
interesting for several reasons. First, SAM is generally a methyl donor, but in the first 
step the ACP group is transferred from SAM. Second, protein posttranslational 
modifications that involve C-C bond formation are rare(6) and in diphthamide 
biosynthesis the C-C bond formation involves the poorly nucleophilic C-2 of the 
imidazole ring. Third, in eukaryotes, this reaction requires four proteins, Dph1-4, 
raising questions about the function of each protein.  
Dph1 and Dph2 share about 20% sequence identity, but are not similar to any 
other protein with known function. Iterative BLAST searches(14) starting with 
Saccharomyces cerevisiae Dph1 or Dph2 generate both proteins from other eukaryotic 
species. In contrast, BLAST searches identify only one protein, Dph2, in archaeal 
species. Archaeal Dph2s are more similar to eukaryotic Dph1 than to Dph2. 
Eukaryotic Dph3 and Dph4 have no orthologs in archaea based on BLAST searches. 
To better understand diphthamide biosynthesis, we initially attempted to reconstitute 
the first step using Pyrococcus horikoshii Dph2 (PhDph2) and translation elongation 
factor 2 (PhEF2) under aerobic conditions without success. The X-ray crystal structure 
of PhDph2 revealed an intriguing constellation of three conserved cysteine residues -- 
each from a different structural domain -- suggestive of an iron-sulfur cluster. 
Subsequently, PhDph2 activity was reconstituted in the presence of dithionite under 
anaerobic conditions. A crystal structure of reconstituted PhDph2 along with UV-Vis, 
EPR, and Mössbauer spectroscopies confirmed the presence of a [4Fe-4S] cluster. 
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Detailed biochemical characterization suggests that the PhDph2-catalyzed reaction 
involves a 3′-amino-3′-carboxypropyl radical intermediate.  The data suggest that 
PhDph2 is a novel SAM-dependent [4Fe-4S]-containing enzyme(15) that catalyzes 
unprecedented chemistry.  
 
Results 
PhDph2 is aerobically inactive  
PhDph2 and PhEF2 were expressed in Escherichia coli and purified under 
aerobic conditions. No activity was observed when using these proteins to reconstitute 
the first step of diphthamide biosynthesis. One explanation for the lack of activity is 
that the reaction requires an oxygen-sensitive cofactor and another is that additional 
proteins or small molecules are required. In the latter case the additional proteins 
might be orthologs of eukaryotic Dph3 and Dph4; however, attempts to reconstitute 
activity under similar conditions using yeast Dph1-4 and eEF2 were also unsuccessful.   
PhDph2 can modify PhEF2 in E. coli cells 
 
 
Figure 2.2. Coexpression of PhDph2 and PhEF2 in E. coli. The coexpression is 
confirmed by western blot against His6 tag. 
 
PhDph2 and PhEF2 were coexpressed in E. coli to determine if PhDph2 is 
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enough to catalyze the diphthamide modification on PhEF2.  The expression of both 
PhDph2 and PhEF2 were confirmed by western blot against His6 tag (Figure 2.2).  
The modification on coexpressed PhEF2 was analyzed by MALDI-MS (Figure 2.3) 
 
 
  
Figure 2.3. The MALDI-MS spectra of PhEF2 expressed alone in E. coli (left) and 
PhEF2 coexpressed with PhDph2 in E. coli (right). The mass of polypeptide with 
unmodified histidine and ACP-modified histidine are 1546 (m/z) and 1647, 
respectively. ACP: 3′-amino-3′-carboxypropyl group. 
 
It shows that PhDph2 can modify PhEF2 in E. coli cell. Therefore the explanation for 
the lack of activity of the aerobically purified PhDph2 is that the reaction may require 
an oxygen-sensitive cofactor. 
Crystal structure of PhDph2 
To provide structural insight into the catalytic mechanism of PhDph2, we 
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determined its X-ray crystal structure at 2.3 Å resolution using selenomethionine 
(SeMet) single anomalous diffraction (SAD) phasing. The structure showed that  
 
 
Figure 2.4.  5Structure of PhDph2 homodimer. The PhDph2 homodimer is shown in 
the ribbon diagram with one monomer in dark color and the other in light color. Each 
monomer is also color by secondary structure. The three conserved cysteine residues 
for each monomer are shown in the stick representation. 
 
PhDph2 is a homodimer (Figure 2.4). Each PhDph2 monomer consists of three 
domains with all three domains sharing the same overall fold. The basic domain fold is 
a four-stranded parallel β-sheet with three flanking α-helices (or two α-helices and 
one 310 helix in the case of domain 2) (Figure 2.5). The two -sheets in domain 1 and 2 
each contains an additional β-strand that is antiparallel to the rest of the -sheet. 
Domains 2 and 3 have two additional α-helices. Domain 1 of one monomer and 
domain 3 of the adjacent monomer form the dimer interface, creating an extended  
                                                 
5 X-ray crystal structure of apo PhDph2 was resolved by Dr. Yang Zhang. 
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Figure 2.5. Three-dimensional structure of PhDph2. a, PhDph2 monomer colored by 
secondary structure. The locations of the three conserved cysteine residues are 
indicated. b, Representative region of a 2Fo-Fc composite omit electron density map 
and the final atomic model for residues 277-283. The map was calculated at 2.1 Å 
resolution and is contoured at 1 σ. c, Topology diagram of PhDph2. The conserved 
secondary structures of the three domains are colored blue for α- helices, lavender for 
a 310-helix, and green for β-strands. 
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Figure 2.6. Sequence alignment for PhDph2 and orthologs. Three additional archaeal 
orthologs are included for comparison: Thermococcus sp. AN4 (Ts), Sulfolobus 
acidocaldarius (Sa) and Methanococcus maripaludis (Mm). Also included are the 
Homo sapiens (Hs) and Saccharomyces cerevisiae (Sc) orthologs of PhDph2: 
HsDph1, ScDph1, HsDph2 and ScDph2. Secondary structural elements are shown 
above each row and are based on the structure of PhDph2. Residues conserved in all 
eight sequences are highlighted in red. Residues with conservative changes are 
highlighted in yellow. The three conserved cysteine residues that bind to the [4Fe-4S] 
cluster of PhDph2 are indicated by red triangles. 
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nine-stranded β-sheet. The domain folds and their arrangement resemble the structure 
of quinolinate synthase(16); however, the orientations of the domains with respect to 
each other are different in the two enzymes. Three conserved cysteine residues 
(Cys59, Cys163 and Cys287), each coming from a different structural domain, are 
clustered together in the center of the PhDph2 monomers. All three cysteine residues 
are conserved in eukaryotic Dph1s. The first and third cysteine residues are conserved 
in eukaryotic Dph2s (Figure 2.6). 
 
Reconstitution of PhDph2 activity 
 
 
Figure 2.7. In vitro reconstitution of PhDph2 activity. a, Activity assay using carboxy-
14C SAM. Top panel shows the Coomassie blue-stained gel; bottom panel shows the 
autoradiography. Lane 1: Protein standard; 2: Blank lane; 3: PhEF2 + SAM, negative 
control; 4: PhDph2 + SAM, negative control; 5: PhEF2 H600A + PhDph2 + SAM, 
negative control; 6: PhEF2 + PhDph2 + SAM + dithionite; 7: PhEF2 + PhDph2 + 
SAM, no dithionite, negative control. b, The MALDI-MS spectra of PhEF2 
unmodified (top) and modified by PhDph2 in an in vitro reaction (bottom). 
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The clustering of the three cysteine residues in the crystal structure and the 
requirement for SAM raised the possibility that PhDph2 utilizes a [4Fe-4S] cluster 
(15). Radical SAM enzymes harbor a [4Fe-4S] cluster coordinated by three cysteines 
in a CX3CX2C motif(17), although variations of this motif have been reported (18), 
(19) to generate a 5´-deoxyadenosyl radical. Since [4Fe-4S] clusters are typically 
oxygen-sensitive, PhDph2 was purified and assayed anaerobically. Using 14C-SAM, 
we showed that PhEF2 can be labeled in the presence of PhDph2 (Figure 2.7a, lane 6), 
but not in the absence of PhDph2 (lane 3) or dithionite (lane 7). When His600 of 
PhEF2, the site of the diphthamide modification, was changed to alanine, no reaction 
occurred in the presence of PhDph2 (lane 5). MALDI-MS of the PhEF2 protein 
confirmed that an ACP group was added after the reaction (Figure 2.7 b). These 
results suggest the possibility that PhDph2 is a SAM-dependent Fe-S enzyme and 
demonstrate that no other enzyme is required for the first step of diphthamide 
biosynthesis in vitro. 
Characterization of the [4Fe-4S] cluster 
The anaerobically purified PhDph2 contains 1.3 ± 0.2 and 1.9 ± 0.2 
equivalents of iron and sulfur per polypeptide, respectively, and displays a broad 
absorption band at ~400 nm, which disappears upon reduction by 0.5 mM dithionite 
(Figure 2.8a). The 400 nm absorption is typical of a [4Fe-4S]2+ cluster. Quantification 
based on the 400 nm absorption suggests the presence of ∼0.3 [4Fe-4S]2+ per PhDph2. 
EPR spectra of dithionite-reduced PhDph2 are shown in Figure 2.8b. The g-values 
(2.03, 1.92, and 1.86) and the temperature-dependence are typical of a [4Fe-4S]+ 
cluster.(20-23) Quantification of the EPR spectrum suggests the presence of ∼0.3 
[4Fe-4S]+ per PhDph2.  The 57Fe-enriched anaerobically-isolated PhDph2 contains 2.0 
± 0.2 and 2.1 ± 0.2 equivalents of iron and sulfur per polypeptide, respectively. The 
4.2-K/53-mT Mössbauer spectrum (Figure 2.8c) is dominated by a quadrupole doublet  
54 
 
 
Figure 2. 8. 6Spectroscopic characterization of the [4Fe-4S] cluster in PhDph2. a, UV-
vis absorption spectra of anaerobically-isolated and dithionite-reduced PhDph2. b, X-
band EPR spectra of dithionite-reduced PhDph2 at different temperature. c, 4.2-K/53-
mT Mössbauer spectrum of anaerobically-isolated 57Fe-labeled PhDph2 expressed in 
E. coli. d, Structure of PhDph2 with [4Fe-4S] cluster. 
 
                                                 
6 Data of EPR spectra was collected and analyzed by Dr. Boris Dzikovski; Micheal Lee performed the 
Mössbauer spectrum; Dr. Andrew T. Torelli determined the crystal structure of PhDph2with iron-sulfur 
cluster. 
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with parameters (isomer shift (δ) of 0.43 mm/s and quadrupole splitting parameter 
ΔEQ) of 1.13 mm/s) typical of [4Fe-4S]2+ clusters (solid line in Figure 2.8 c, 73% of 
total intensity). The weak absorption peak labeled (a) suggests the presence of a small 
amount (~10%) of high-spin Fe (II), which is presumably nonspecifically bound to the 
protein. The shoulder labeled (b) belongs to a quadrupole doublet (~15% intensity), 
the left line of which contributes to the prominent peak at -0.2 mm/s. Although the 
nature of the Fe species that gives rise to this absorption is not known, similar spectral 
features were observed for a sample of P. horikoshii quinolinate synthase,(24) which 
is structurally similar to PhDph2 and also harbors a [4Fe-4S] cluster (Figure 2.8d). 
Thus, all the spectroscopic data indicate that PhDph2 contains a [4Fe-4S] cluster. 
Brown crystals of the anaerobically purified PhDph2 were obtained that belong 
to the same space group as the inactive PhDph2. A crystal structure determined to 2.1 
Å resolution showed clear electron density for a [4Fe-4S] cluster.  Refinement of the 
PhDph2 structure with a [4Fe-4S] cluster included gave final R and Rfree values of 
20.4% and 25.2%, respectively. 
 
Reaction mechanism 
To explore the PhDph2 reaction mechanism, HPLC was used to analyze the 
reaction products. In the reaction that contained SAM, PhDph2, PhEF2 and dithionite, 
most SAM molecules were converted to 5´-deoxy-5´-methylthioadenosine (MTA) In 
control reactions without PhDph2 or dithionite, only low levels of MTA were 
observed and most SAM molecules were left intact. This is consistent with the activity 
assay results shown in Figure 2.9. Cleavage of the C5´-S bond of SAM did not occur  
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Figure 2. 9. HPLC analysis of reaction products suggests PhDph2 does not form 5´-
deoxyadenosine, instead of MTA structure is shown at the right side. 
 
because the formation of 5´-deoxyadenosine (the most likely product of the adenosyl 
moiety) was not observed. Collectively, the results suggest that PhDph2 catalyzes the 
cleavage of the Cγ,Met-S bond of SAM only in the presence of reductant, transfers the 
ACP group to PhEF2, and releases the remaining MTA. 
Two different mechanisms can be proposed for the PhDph2-catalyzed cleavage 
of the Cγ,Met-S bond of SAM. One is that the [4Fe-4S]+ cluster provides one electron to 
reductively cleave the Cγ,Met-S bond of SAM, forming MTA, an ACP radical, and the 
oxidized [4Fe-4S]2+ cluster (Figure 2.11a). Alternatively, the [4Fe-4S] cluster in 
PhDph2 binds SAM and orients it correctly for nucleophilic attack by the C2 of the 
57 
 
Figure 2.10. NMR spectra of standard compounds, products from PhDph2 reaction, 
and products from the control reaction without PhDph2. These spectra are overlaid so 
that it is easy to tell which compound is present in the reaction or control. Homoserine 
lactone (peaks marked with green arrows) and unreacted SAM were the major 
identifiable compounds present in the control reaction without PhDph2. In the reaction 
with PhDph2, the major identifiable compounds are HSA (peaks marked by cyan 
arrows) and ABA (peaks marked by magenta arrows). 
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Figure 2.11. Two possible reactions mechanisms proposed for PhDph2 based on the 
observation made in Figure 5a. (a) A radical mechanism. The [4Fe-4S]+ cluster 
provides an electron to reductively break the Cγ,Met-S bond of SAM, generating a 3-
amino-3-carboxypropyl radical, which then adds to the imidazole ring. The resulting 
radical then loses one electron and one proton to give the product. (b) A nucleophilic 
mechanism. The [4Fe-4S]+ serves to anchor SAM in the right position and orientation 
for nucleophilic attack by the C2 position of the imidazole ring. Deprotonation of the 
resulting adduct then gives the product. 
 
imidazole ring (Figure 2.11b), leading to the formation of products. Further evidence 
to differentiate these two possibilities was provided by the identification of the product 
derived from the ACP group in the reaction without PhEF2. In the absence of PhEF2, 
PhDph2 can still cleave the Cγ,Met-S bond of SAM, generating MTA (Figure 2.9). The 
fate of the ACP group was interrogated by 1H-NMR (Figure 2.10). In the reaction 
containing PhDph2, SAM, and dithionite, several new peaks were observed, which 
were not observed in control samples without dithionite or PhDph2 (Figure 2.10). 
These peaks were assigned to two products: 2-aminobutyric acid (ABA) and 
homocysteine sulfinic acid (HSA). The NMR spectra of authentic samples of ABA 
and HSA confirmed these assignments (Figure 2.10). In Figure 2.10, these NMR 
spectra were compared to those of homoserine, homoserine lactone, and SAM, ruling 
out the possibility that PhDph2 catalyzes the formation of homoserine or homoserine 
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lactone via a nucleophilic mechanism. 
To further validate these results, the reaction mixtures were purified by TLC, 
dansylated, and subsequently analyzed by LCMS. The structures and molecular 
weights of the dansylated compounds are shown in Figure 2.12. In the control reaction 
without PhDPh2, the formation of dansylated homoserine (m/z 337, MH+, retention 
time 18.35 min) was observed (Figure 2.13), which is consistent with the NMR results 
(Figure 2.10). In the reaction with PhDph2, SAM, and dithionite, the formation of 
dansylated homoserine was suppressed compared with the control. Instead, dansylated 
ABA (m/z 337, MH+, 23.60 min) and HSA (m/z 401, MH+, 16.65 min) were observed 
(Figure 2.13). Dansylated homoserine lactone and ABA have the same retention time, 
but can be differentiated by their m/z-values (337 and 335 for ABA and homoserine 
lactone, respectively). During the TLC purification and dansylation reaction, HSA was 
partially oxidized to homocysteine sulfonic acid, as evidenced by the ion with m/z 417 
(MH+, Figure 2.13).   
 
 
Figure 2. 12. The structures and molecular weights of the dansylated compounds that 
can possibly form in the PhDph2-catalyzed cleavage of SAM. Whether these 
compounds were produced or not were checked by LCMS in Figure 2.13c. 
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Figure 2. 13. Detection of dansylated reaction products by LCMS. The MS traces 
(total ion counts and ion counts for specific compounds) were shown for the reaction 
with PhDph2, control reaction without PhDph2, and ABA and HSA standards 
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Overall, the results from the LCMS analysis and NMR analysis demonstrate 
that PhDph2 catalyzes the formation of ABA and HAS in the absence of PhEF2. The  
formation of ABA and HSA can be best explained by the generation of an ACP radical 
followed by hydrogen extraction to give ABA or quenching by dithionite to give HSA. 
 
 
Figure 2.14. The proposed reaction mechanism for PhDph2. The formation of ABA 
and HSA can be best explained by a 3-amino-3-carboxypropyl radical intermediate. 
The radical can be generated by electron transfer from the [4Fe-4S] cluster, similar to 
the generation of 5´-deoxyadenosyl radical in other radical SAM enzymes. In the 
presence of PhEF2, the radical will react with PhEF2 to form the modified PhEF2 
product. In the absence of PhEF2, the radical can either abstract a hydrogen atom to 
form ABA or be quenched by dithionite to give HSA. 
 
Discussion  
The biochemical, structural and spectroscopic data presented here establish 
that PhDph2 is a novel [4Fe-4S] cluster enzyme. PhDph2 cleaves the Cγ,Met-S bond of 
SAM to MTA and transfers the ACP group to His600 of PhEF2. This reaction is 
strictly dependent on the presence of reductant. In the absence of the natural substrate, 
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PhEF2, the ACP moiety is trapped either as ABA or as HSA, which suggests the 
intermediacy of an ACP radical. The reductive cleavage of SAM to a thioether and an 
alkyl radical by a reduced [4Fe-4S]+ cluster is the hallmark feature of the superfamily 
of radical SAM enzymes.(15) However, there are two crucial differences between the 
radical SAM enzymes and PhDph2. First, the radical SAM enzymes exclusively 
cleave the C5´-S bond to generate methionine and a 5´-deoxyadenosyl radical, which 
is used for a variety of downstream C-H cleavage reactions. Second, the radical SAM 
superfamily is characterized by a conserved CX3CX2C motif(17) (or CX2CX4C in 
ThiC(18), or CX5CX2C in HmdA(19)) that binds the [4Fe-4S] cluster. This motif is 
not present in PhDph2. Instead the three conserved cysteine residues are located in 
separate structural domains and are separated by more than 100 residues in the 
sequence. Consequently, the three-dimensional structure of PhDph2 is distinct from 
the structures of the known radical SAM enzymes BioB,(25) HemN,(26) LAM,(27) 
MoaA,(28) PFL-AE,(29) and ThiC(18), which all have β-barrel or modified β-barrel 
folds. PhDph2 is structurally similar to quinolinate synthase,(16) which is also 
composed of three structurally homologous domains in a triangular arrangement. The 
triangular arrangement of domains in PhDph2 positions the three conserved cysteine 
residues in the central cavity to bind the [4Fe-4S] cluster. In quinolinate synthase, the 
three conserved cysteine residues required to bind the cluster are also widely separated 
in the amino acid sequence and located in different domains.(30),(23) However, 
quinolinate synthase is not SAM-dependent and its proposed role is in the dehydration 
of the penultimate precursor of quinolinate.(23)  In addition, the IspH enzyme in the 
non-mevalonate pathway for isoprenoid biosynthesis also uses a similar triangular 
arrangement to bind a [3Fe-4S] cluster.(31) 
It is likely that the different reaction outcome, i.e. cleavage of the C5´-S bond 
in the radical SAM enzymes vs. cleavage of the Cγ,Met-S bond in PhDph2, is controlled 
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by different orientations of SAM relative to the [4Fe-4S] cluster. In the radical SAM 
enzymes, the amino and carboxyl groups of SAM coordinate to the non-cysteine-
ligated Fe site of the [4Fe-4S] cluster.(32) Future structural and spectroscopic studies 
are required to investigate how SAM is bound at the active site of PhDph2.  
Our data demonstrated that PhDph2 is the only gene product required to 
catalyze the first step of diphthamide biosynthesis in vitro. In contrast, biosynthesis of 
diphthamide in eukaryotes requires four gene products, Dph1-4. Studies on PhDph2 
provide important insight into the functions of eukaryotic Dph1-4. The crystal 
structure shows that PhDph2 is a homodimer. Eukaryotic Dph1 and Dph2 are both 
homologous to each other and to archaeal Dph2. In addition, Dph1 and Dph2 in 
eukaryotes form a heterodimer.(3, 33-35) Therefore it is possible that the eukaryotic 
Dph1-Dph2 heterodimer is structurally homologous to the PhDph2 homodimer. The 
three cysteine residues required to bind the cluster are conserved in Dph1 and two of 
the cysteine residues are conserved in Dph2. Thus the heterodimer of Dph1-Dph2 
should at least bind one [4Fe-4S] cluster and may be sufficient to catalyze the first step 
in vitro. Dph2, which only has two of the conserved Cys residues, could either have a 
different catalytic function than Dph1 or could be regulatory. In vivo, Dph3 and Dph4 
are also required for diphthamide biosynthesis.(3) These gene products may be 
required to keep the [4Fe-4S] cluster in a reduced state. This hypothesis is supported 
by the observation that Dph3 can bind iron and is redox active.(36) Alternatively 
Dph3 and Dph4 may be required for proper assembly of the [4Fe-4S] clusters. The Fe-
S cluster assembly pathways in bacteria and mitochondria of eukaryotes are known to 
involve J domain-containing co-chaperone proteins, such as bacterial HscB and yeast 
JAC1(37, 38), that are similar to Dph4. Confirmation of these functional assignments 
awaits detailed biochemical and structural studies. 
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Experimental 
Cloning, expression and purification of PhDph2 under anaerobic conditions 
The gene encoding P. horikoshii Dph2 was amplified by PCR from 
Pyrococcus horikoshii genomic DNA and inserted into pENTRTM/TEV/D-TOPO® 
entry vector (Invitrogen), followed by recombination with pDESTF1 destination 
vector to create expression clones with an N-terminal His6 tag. The plasmids were 
transformed into the E. coli expression strain BL21(DE3) with pRARE. The cells were 
grown in LB media with 100 g/ml ampicillin at 37 　 °C and were supplemented with 
FeCl3, Fe(NH4)2(SO4)2 and L-cysteine to final concentrations of 50 µM, 50 µM and 
400 µM, respectively, when the absorbance of the cell culture reached an OD600 of 0.8. 
The cells were induced at an OD600 of 0.8 – 1.0 with 0.1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG), at which point the culture flasks were sealed to limit 
the amount of oxygen in the system. The induced cells were incubated in a shaker 
(New Brunswick Scientific Excella E25) at 37 °C and 200 rpm for 3 h before being 
transferred to the 4 °C cold room, where they were kept overnight without agitation. 
Cells were harvested the second day by centrifugation at 6,371 g (Beckman Coulter 
Avanti J-E), 4 °C for 10 min. Purification of PhDph2 was performed in an anaerobic 
chamber (Coy Laboratory Products) except for the centrifugation step. Cell pellets 
(from 2 l LB culture) were re-suspended in 30 mL lysis buffer (500 mM NaCl, 10 mM 
MgCl2, 5 mM imidazole, 1 mM DTT and 20 mM Tris-HCl at pH 7.4). Cells were 
lysed by incubating with 0.3% (w/v) lysozyme (Fisher) at 26 °C for 1 h, followed by 
freezing in liquid nitrogen and thawing at 26 °C once. Cell debris was removed by 
centrifugation at 48,384 g (Beckman Coulter Avanti J-E) for 30 min. The supernatant 
was incubated for 1 h with 1.2 ml Ni-NTA resin (Invitrogen) pre-equilibrated with the 
lysis buffer. The resin after incubation was loaded onto a polypropylene column and 
washed with 20 ml lysis buffer. PhDph2 was eluted from the column with elution 
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buffers (100 mM or 150 mM imidazole in the lysis buffer, 3 ml each). The brown-
colored elution fractions were buffer exchanged to 150 mM NaCl, 1 mM DTT, and 
200 mM Tris-HCl at pH 7.4 using a Bio-Rad 10–DG desalting column. The protein 
was further purified by heating at 95 °C for 10 min and centrifugation at 48,384 g to 
remove the precipitate. Purified PhDph2 was concentrated using Amicon Ultra-4 
centrifugal filter devices (Millipore). 
Expression and purification of SeMet substituted PhDph2 
PhDph2.pDESTF1 was transformed into the methionine-auxotrophic E. coli 
strain B834(DE3) pRARE that was obtained by transforming pRARE plasmid into 
B834(DE3). Cells were grown in M9 minimal medium supplemented with all amino 
acids (0.04 mg/mL) except L-methionine, 50 mg/l L-SeMet, 1x MEM vitamin 
solution, 0.4% (w/v) glucose, 2 mM MgSO4, 25 mg/ml FeSO4 and 0.1 mM CaCl2. The 
SeMet substituted PhDph2 was overexpressed and purified similarly as described 
above except aerobically and no additional iron and cysteine were added to the media. 
Expression and purification of 57Fe-labeled PhDph2 for Mössbauer spectroscopy. 
E. coli BL21pRARE cells transformed with PhDph2.pDESTF1 were grown in 
M9 minimal medium supplemented with 0.2% (w/v) glucose, 2 mM MgSO4 and 0.1 
mM CaCl2 at 37 °C. The 57Fe stock solution was prepared by dissolving 57Fe powder 
(Isoflex USA) in HCl to final concentrations of 1 M iron and 2.5 M chloride. The 57Fe 
stock solution and L-Cys were added to M9 media to final concentrations of 100 µM 
and 400 µM, respectively, before induction. The cells were induced at an OD600 of 0.8 
with 100 µM IPTG and incubated at 20 °C for an additional 20 h. 57Fe labeled PhDph2 
was anaerobically purified by following the same procedure used for the native protein 
purification. The final protein concentration, determined by Bradford protein assay 
(Bio-Rad), was 30 mg/ml (~800 µM). Iron was quantified by using the commercial 
Quantichrom iron assay kit (DIFE-250, Bioassay systems). 
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Cloning, expression and purification of PhEF2 
Cloning of PhEF2 followed the same protocol as that of PhDph2. The plasmid 
was transformed into the E. coli expression strain, BL21 (DE3) with a pRARE 
plasmid. The cells were grown in LB media at 37 °C and induced at an OD600 of 1.0 
with 0.1 mM IPTG. Cells were harvested after 3 h of induction by centrifugation at 
6,000 rpm for 10 min. PhEF2 was purified through Ni-NTA affinity chromatography 
following the same protocol for PhDph2. The protein was further purified by heating 
at 95 °C for 10 min and subsequent FPLC purification using a Superdex 200 gel 
filtration column and a Q6 anion exchange column (Bio-Rad). 
Anaerobic reconstitution of PhDph2 activity and mass characterization of PhEF2  
The reaction components, 12 µM PhEF2, 24 µM PhDph2, and 10 mM 
dithionite were added to 150 mM NaCl, 1 mM DTT, and 200 mM Tris-HCl at pH 7.4 
to a final volume of 15 µl in the anaerobic chamber under strictly anaerobic 
conditions. The reaction vials were sealed before taking out of the anaerobic chamber. 
14C-SAM (2µL, final concentration of 267 µM) was injected into each reaction vial to 
start the reaction. The reaction mixtures were vortexed briefly to mix and incubated at 
65 °C for 40 min. The reaction was stopped by adding protein loading dye to the 
reaction mixture and subsequent heating at 100 °C for 10 min, followed by 12% SDS-
PAGE electrophoresis. The dried gel was exposed to a PhosphorImaging screen (GE 
Healthcare, Piscataway, NJ) and the radioactivity was detected using a STORM860 
phosphorimager (GE Healthcare, Piscataway, NJ).  
Enzymatic reactions with normal SAM followed the same procedure, except 
that normal SAM was introduced in the anaerobic chamber. The PhEF2 band from the 
Coomassie blue-stained SDS-PAGE gel was cut out and digested by trypsin. Digestion 
products were extracted and cleaned using a Millipore Ziptip C4, then characterized 
by MALDI-MS at the Proteomics and Mass Spectrometry Facility of Cornell 
67 
University. 
Analysis of reaction products with HPLC  
Under anaerobic conditions, reactions were set up that contained 30 µM 
PhEF2, 30 µM PhDph2, 10 mM dithionite, 31 µM SAM, 150 mM NaCl, 1 mM DTT, 
and 200 mM Tris-HCl at pH 7.4 in a final volume of 64 µl. The mixture was incubated 
at 65 °C for 5 min, and then frozen at -20 °C. The reaction mixture was ice-thawed 
and TFA was added to a final concentration of 5%, followed by centrifugation to 
separate the precipitated proteins and the supernatant. The precipitated proteins were 
re-dissolved and PhEF2 was checked by MALDI-MS as described above to make sure 
the reaction had occurred. The supernatant was analyzed by HPLC (Shimadzu) on a 
C18 column (HαSprite) monitored at 260 nm absorbance, using a linear gradient from 
0 to 40% buffer B in 20 min at a flow rate of 0.3 ml min-1 (buffer A: 50 mM 
ammonium acetate, pH 5.4; buffer B, 50% (v/v) methanol/water). 
1H NMR of reaction mixture 
A complete reaction (260 µM PhDph2, 10 mM dithionite and 1000 µM SAM, 
in 1 ml of 100 mM phosphate buffer with 150 mM sodium chloride, pH=7.4) and 
control (without PhDph2 or without dithionite) were set up anaerobically. After 
incubation at 65 °C for 40 min, PhDPh2 was removed using a Millipore YM-10 
Microcon filter unit. The flow-through was lyophilized overnight to dryness and then 
dissolved in 300 µL D2O for NMR. Shigemi D2O matched NMR tube was used. 1H 
NMR spectra were obtained on an INOVA 400 spectrometer. Compared with controls, 
four new peaks were identified on 1H NMR: a. 0.95 ppm (t, 1H, J = 7.6 Hz), b. 1.88 
ppm (m, 1H), c. 2.12 ppm (m, 2H) and d. 2.43 ppm (t, 1H, J = 7.5 Hz). H-H DQCOSY 
2D NMR spectrum (data not shown) showed that peak a is coupled to b, peak c is 
coupled to d and another peak (3.78 ppm) that is hidden under the huge signal from 
buffer. NMR data were analyzed by MestReNova (version 6.0.1). 
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Dansylation reaction to detect the MS of the reaction products by LC-MS 
NMR samples were desalted and purified by TLC silica gel 60F254 (EMD 
Chemicals Inc.) with developing solvent (n-butanol : acetic acid : water = 2:1:1). The 
desired product bands (Rf  0.15 -0.65, below the Rf value of 5´-deoxy-5´-
methylthioadenosine) were cut off the TLC plates and the products were washed off 
the silica gel by water and lyophilized overnight to dryness. The lyophilized products 
were dissolved with 50 mM sodium bicarbonate to a final concentration approximately 
5 times of that of the NMR reaction. The solution was adjusted to pH 9-10 by 12% 
NaOH. Dansylation reactions were initiated by adding 0.5 volume of 50 mM dansyl 
chloride in acetonitrile to the solution and the reactions were carried out at room 
temperature in the dark for 30 min. Dansylated products were separated and analyzed 
by LC-MS with a linear gradient 0-80% solvent B in 33 min, at a flow rate of 0.8 
ml/min.  LC-MS experiments were carried out on a SHIMADZU LCMS-QP8000α 
with C18 column (250 × 4.6 mm, 10 μm, Grace Davison Discovery Sciences 
Headquarters) monitoring at 254 and 335 nm with positive mode for mass detection. 
Solvents for LC-MS were water with 0.1% formic acid (solvent A) and acetonitrile 
with 0.1% formic acid (solvent B). 
Sample preparation for Mössbauer spectroscopy and EPR  
Anaerobically purified 57Fe-labeled PhDph2 was dialyzed into a buffer 
containing 200 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM DTT and 10% glycerol, 
and concentrated to 25 – 30 mg/mL. The sample was frozen in liquid nitrogen in the 
anaerobic chamber for Mössbauer spectroscopy. 
For EPR measurements, PhDph2 (700 μM, with 15% glycerol) with and 
without 16 mM dithionite were incubated for 30 min before loading into an EPR 
quartz tube in the glovebox.  
Crystallization and structure determination of iron-free PhDph2 
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Aerobically purified iron-free PhDph2 proteins were dialyzed to 10 mM 
sodium acetate at pH 4.6 and concentrated to 12 mg/ml for the crystallization 
experiments. The native protein was subjected to a series of sparse matrix screens 
(Hampton Research, Emerald Biostructures) using the hanging drop vapor-diffusion 
method at 18 °C in order to determine initial crystallization conditions. Best crystals 
for both SeMet substituted and native PhDph2 were obtained from 6 – 8% PEG 4000, 
0.1 M ammonium acetate, 0.2 M KCl, 2% ethylene glycol, and 0.05 M sodium citrate 
at pH 5.1 – 5.3. These crystals belong to the space group P212121 with typical unit cell 
dimensions of a = 58.5 Å, b = 82.0, and c = 160.0 Å. Each asymmetric unit contains 
two monomers, corresponding to a solvent content of 50.3% and Matthews coefficient 
of 2.47 Å3/Da.  
The PhDph2 SeMet crystals were briefly transferred into a solution containing 
6% glycerol, 16% ethylene glycol, 10% PEG 4000, 0.2 M ammonium acetate, 0.2 M 
KCl, and 0.1 M sodium citrate at pH 5.3 for cryoprotection. The crystals were allowed 
to soak in the cryo-solution for 30 – 45 s before plunging them into liquid nitrogen. In 
an attempt to reconstitute the iron sulfur clusters in crystals, native crystals were 
soaked in 10% PEG 4000, 100 mM citrate pH 5.3, 200 mM ammonium acetate, 200 
mM KCl, 10% ethylene glycol, 8 mM SAM, 4 mM Fe(NH4)2(SO4)2, 4 mM NaS, and 
40 mM DTT for 1 h prior to the same cryoprotection and freezing procedure described 
above. 
 Data sets were collected at the Advanced Photon Source beamlines 24-ID-C 
and 24-ID-E using ADSC Quantum 315 CCD detectors. For the single wavelength 
SeMet data set, the energy was selected to maximize Δf" of the incorporated selenium 
(12661.5 eV, 0.97922 Å). Data sets were integrated and scaled using HKL2000(39). 
Data processing statistics are summarized in Supplementary Table 1. 
 Eight selenium atom positions were determined using HKL2MAP(40). These 
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sites were used for SAD phasing using MLPHARE(41) at 2.5 Å resolution. Initial 
phases were further improved through density modification, twofold 
noncrystallographic symmetry averaging, and phase extension for the 2.3 Å resolution 
native data using RESOLVE.(42, 43) The resulting map was readily interpretable and 
an initial model was built using the interactive graphics program Coot(44). The model 
refinement was carried out through alternating cycles of manually rebuilding using 
Coot, restrained refinement and water picking using Refmac5(45) and Phenix(46).  
Crystallization and structure determination of reconstituted PhDph2.   
Reconstituted PhDph2 protein was dialyzed to 100 mM NaCl, 1 mM DTT, and 
10 mM sodium acetate at pH 4.6, concentrated to 20 mg/ml, and crystallized 
anaerobically at 26 °C in the glove box using the hanging drop vapor diffusion 
method. Anoxic sparse matrix screening solutions (Hampton Research, Emerald 
Biostructures) were used for initial crystallization screens. The optimized 
crystallization condition is as follows: drops were set up with 1.3 μl protein and an 
equal volume of 25 – 30% PEG 400, 0.2 M lithium sulfate and 0.1 M MES at pH 6.5, 
and were equilibrated against a reservoir solution of 0.6 M lithium chloride. Crystals 
appeared in a week and belonged to the same space group as that of the iron-free 
structure (P212121 with averaged unit cell dimensions of a = 55.7 Å, b = 80.5 Å and c 
= 162.1 Å). Prior to the data collection experiment, crystals were cryoprotected with 
2.5 – 5% ethylene glycol, 25 – 30% PEG 400, 0.2 M lithium sulfate, and 0.1 M MES 
at pH 6.5, then plunged directly into liquid nitrogen in the glove box. A total of 200° 
of data were recorded at an energy of 12662.0 eV on an ADSC Quantum 315 CCD 
detector. The data were integrated and scaled to 2.1 Å resolution using HKL2000(39). 
The previously solved structure of PhDph2 lacking the iron sulfur cluster was used to 
generate phases by Fourier synthesis. A difference Fourier map was calculated and 
averaged for the two monomers to improve the electron density, and the resulting map 
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was used to model the [4Fe-4S] cluster. A 2.8 Å resolution anomalous difference 
Fourier map calculated from a data set collected at 7150 eV (1.73405 Å) was also used 
as a reference for positioning the [4Fe-4S] cluster (not shown). The structure was 
refined using CNS(47). 
UV-Vis spectroscopy.  
Samples of PhDph2 (50 µM), with and without dithionite, were prepared 
anaerobically in 150 mM NaCl and 200 mM Tris-HCl at pH 7.4. The sample treated 
with dithionite was allowed to incubate for 30 min after adding the reducing agent at a 
final concentration of 0.5 mM. The samples were sealed in a Quartz cell (100 µl each) 
before taking out from the anaerobic chamber. UV-Vis spectra were obtained on a 
Cary 50 Bio UV-Visible spectrophotometer (Varian), scanning from 200 nm to 800 
nm. The baseline was corrected with the buffer used to prepare the samples. 
EPR spectroscopy.  
ESR spectra were recorded at ACERT on a Bruker EMX spectrometer at a 
frequency of 9.24 GHz under standard conditions in 4 mm ID quartz tubes. The tubes 
were filled with PhDph2 solutions in an oxygen-free atmosphere and sealed under 
vacuum at 77 K. ESR measurements at 5-50 K were carried out using a liquid helium 
cryostat, ESR-10 (Oxford Instruments Ltd, England). The spectrometer settings were: 
modulation frequency 100 kHz, modulation amplitude 8 G, microwave power 0.63 
mW. 
Mössbauer spectroscopy.  
Mössbauer spectra were recorded on a spectrometer from WEB research 
(Edina, MN) operating in the constant acceleration mode in transmission geometry. 
Spectra were recorded with the temperature of the sample maintained at 4.2 K using a 
SVT-400 cryostat from Janis (Wilmington, MA) in an externally applied magnetic 
field of 53 mT oriented parallel to the γ-beam. The quoted isomer shifts are relative to 
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the centroid of the spectrum of a foil of α-Fe metal at room temperature. Data analysis 
was performed using the program WMOSS from WEB research. 
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CHAPTER 3 
 
MECHANISTIC UNDERSTANDING OF PYROCOCCUS HORIKOSHII 
DPH2, A [4Fe-4S] ENZYME REQUIRED FOR DIPHTHAMIDE 
BIOSYNTHESIS∗ 
Abstract 
Diphthamide, the target of diphtheria toxin, is a unique posttranslational 
modification on eukaryotic and archaeal translation elongation factor 2 (EF2). The 
proposed biosynthesis of diphthamide involves three steps and we have found that in 
Pyrococcus horikoshii (P. horikoshii), the first step uses a S-adenosyl-L-methionine 
(SAM)-dependent [4Fe-4S] enzyme, PhDph2, to catalyze the formation of a C-C 
bond.  Crystal structure shows that PhDph2 is a homodimer and each monomer 
contains three conserved cysteine residues that can bind a [4Fe-4S] cluster. In the 
reduced state, the [4Fe-4S] cluster can provide one electron to reductively cleave the 
bound SAM molecule. However, different from classical radical SAM family of 
enzymes, biochemical evidence suggests that a 3-amino-3-carboxypropyl radical is 
generated in PhDph2. In this chapter I present evidence supporting that the 3-amino-3-
carboxypropyl radical does not undergo hydrogen abstraction reaction, which is 
observed for the deoxyadenosyl radical in classical radical SAM enzymes. Instead, the 
3-amino-3-carboxypropyl radical is added to the imidazole ring in the pathway 
towards the formation of the product. Furthermore, the data suggest that the chemistry 
requires only one [4Fe-4S] cluster to be present in the PhDph2 dimer.  
 
 
                                                 
∗ Reproduced with permission from Zhu, X. et al.  Mol Biosyst. 2011 Jan 1;7(1):74-81. Epub 2010 Oct 
8.Copyright 2011 © Royal Society of Chemistry 2010. 
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Introduction 
Diphthamide, found in both eukaryotes and archaea (1-3), is a unique 
posttranslational modification on a histidine residue of translational elongation factor 
2 (EF2). EF2 is a GTPase required for ribosomal protein synthesis (4). Diphthamide is 
the target of diphtheria toxin(5), which ADP-ribosylates diphthamide and inhibits 
protein synthesis, leading to host cell death(6). Diphthamide was reported to help 
prevent -1 frame shift mutation during protein synthesis(7). The biosynthesis of the 
modification is still not completely understood(8), despite the fact that the 
modification has been identified for over three decades.(1) Genetic studies have 
identified five genes, Dph1, Dph2, Dph3, Dph4, and Dph5, in eukaryotes required for 
the biosynthesis of diphthamide and a three-step biosynthesis pathway involving these 
genes has been proposed(9, 10). The first step is the transfer of the 3-amino-3-
carboxypropyl group from S-L-adenosylmethionine (SAM) to the C-2 position of the 
imidazole ring of the target histidine residue in EF2. Dph1-4 are known to be required 
for the first step (6, 9, 11-15). The second step, catalyzed by Dph5 (16), is the 
trimethylation of the amino group to form an intermediate compound called diphthine. 
The last step is the ATP-dependent amidation of the carboxyl group of diphthine 
(Figure 3.1).  The enzyme that catalyzes the last step has not been identified.  
Diphthamide is also found in archaea. However, among the five eukaryotic 
genes required for diphthamide biosynthesis, only two orthologs can be found in 
archaea by BLAST search. One of them, Dph2, is homologous to eukaryotic Dph1 and 
Dph2 (Dph1 and Dph2 are homologous to each other), and the other one is the 
diphthine synthase, Dph5. 
We have successfully reconstituted the first step of diphthamide biosynthesis 
using the Pyrococcus horikoshii Dph2 (PhDph2) and EF2 (PhEF2) (Figure 3.1). 
PhDph2 forms a homodimer. Each monomer has three conserved cysteine residues 
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(Cys59, Cys163 and Cys287) that can bind a [4Fe-4S] cluster. Similar to radical SAM 
enzymes, the [4Fe-4S] cluster in PhDph2 binds SAM and in the reduced state can 
provide one electron to reductively cleave SAM. However, unlike radical SAM 
enzymes, our evidence suggest that PhDph2 generates a 3-amino-3-carboxypropyl 
(ACP) radical, instead of a 5’-deoxyadenosyl radical (17).   
 
 
Figure 3.1. Diphthamide biosynthesis pathway 
 
Although our previous study suggests that an ACP radical is responsible for 
the C-C bond formation reaction(17), details of the reaction mechanism still need to be 
determined. For example, how does the ACP radical react with the imidazole ring to 
form the C-C bond? Does the reaction require each of the monomers to contain a [4Fe-
4S] cluster, or is only one [4Fe-4S] cluster per dimer sufficient? These two questions 
may be connected to each other, as indicated by the two possible mechanistic 
proposals shown in Figure 3. 2. Here we report our efforts in trying to differentiate 
these two mechanisms using mutagenesis to generate a “heterodimer” of PhDph2, 
with one wild type monomer that contains a [4Fe-4S] cluster while the other mutant  
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Figure 3.2. Two possible mechanisms for PhDph2-catalyzed reaction. a. One [4Fe-
4S] cluster per PhDph2 dimer is sufficient for the reaction and the ACP radical adds to 
the imidazole ring; b. Two [4Fe-4S] clusters per PhDph2 dimer are required for the 
reaction.  The ACP radical abstracts a hydrogen atom from the imidazole ring. As a 
consequence, one reaction needs two SAM with one ACP transferred to PhEF2 and 
the other one released as 2-aminobutyric acid. 
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monomer is incapable of binding a [4Fe-4S] cluster. Our evidence suggests that the 
chemistry only requires one [4Fe-4S] cluster to be present per PhDph2 dimer, 
consistent with the mechanism in Figure 3. 2a. In addition, in the presence of PhEF2, 
we showed that 2-aminobutyrate is not formed, further supporting the mechanism 
shown in Figure 3. 2a.  
 
Results 
Single cysteine to alanine mutants of PhDph2 can still bind [4Fe-4S] clusters while 
double mutants cannot.  
Our previous work showed that PhDph2 forms a homodimer and each 
monomer contains three conserved cysteine residues (Cysteine59, Cysteine163 and 
Cysteine287) that can bind a [4Fe-4S] cluster. In order to make a PhDph2 heterodimer 
with only one subunit capable of binding a [4Fe-4S] cluster, we decided to mutate 
these conserved cysteine residues to alanine. All three single mutants (C59A, C163A 
and C287A) purified anaerobically have a brown color, similar to that of wild type 
PhDph2, indicative of  the binding of a [4Fe-4S] cluster. Ultraviolet-visible (UV-Vis) 
spectroscopy and electron paramagnetic resonance (EPR) spectroscopy were obtained 
to further confirm that these single mutants can bind an Fe-S cluster. All three single 
mutants of PhDph2 have absorption at 400 nm, similar to the wild type PhDph2 
(Figure 3.3a). The absorption disappears upon reduction by 0.5 mM dithionite (Figure 
3.3b). The 400 nm absorption is consistent with several known radical SAM enzymes, 
including AtsB(18), HemN(19), and MoaA(20). Upon reduction with dithionite, the 
wild type PhDph2 shows a strong EPR absorption with an average g factor of ~ 1.935 
(Figure 3.3c). The temperature dependence of the EPR spectrum, which is best 
resolved at ~ 12K and becomes unobservable above 30K, is typical for rapidly 
relaxing [4Fe – 4S]1+ clusters.  EPR spectra of PhDph2 single mutants are in general  
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Figure 3.3. Spectroscopic characterization of PhDph2 mutants. a. UV-Vis spectra of 
purified PhDph2 wild type (black line), single mutants: C59A (blue line), C163A (red 
line), C287A (green line) and double mutant(pink line); b. UV-Vis spectra of PhDph2 
C59A with and without dithionite; c. EPR spectra of wild type PhDph2 and its single 
mutants in the reduced  dithionite reduced state at 12 K. The principal values of g-
factor for the main spectral component (shown for wild type and C163A with arrows 
of corresponding color) are: WT: 2.03, 1.92, 1.86; C287A: 2.01, 1.94, 1.88.  S59A: 
2.03, 1.94, 1.90; C163A: 2.11, 1.91, 1.793;  
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very similar to wild type (Figure 3.3c), suggesting that they do bind Fe-S cluster.  The 
most remarkable difference in the EPR spectrum of the reduced form is observed for 
C163A, which exhibits pronounced rhombic main features with greatly increased g-
value anisotropy. For both C59A and C287A, the g-tensors are more axial than wild 
type. The changes in EPR spectra in the mutants probably reflect the changes of the 
local environment introduced by the mutation. 
We next constructed a double cysteine mutant of PhDph2, C59A/C287A. This 
double mutant, when anaerobically purified, has no color, indicating the lack of Fe-S 
cluster. UV-Vis spectrum (Figure 3.3a, pink line) confirmed the lack of Fe-S cluster. 
Thus, the single cysteine mutant can bind Fe-S cluster whereas the double mutant 
cannot. 
Single mutants of PhDph2 have activity and the double mutant does not.  
Wild type PhDph2 can catalyze the transfer of 3-amino-3-carboxypropyl group 
from SAM onto His600 of PhEF2, which can be detected by autoradiography if 
carboxy-14C-SAM is used. MTA, the small molecule product derived from SAM, can 
be monitored by HPLC (17). Using these two methods, we tested whether the single 
and double cysteine mutants of PhDph2 have activity or not (Figure 3.4). All three 
single mutants (C59A, C163A and C287A) were able to transfer the ACP group onto 
His600 of PhEF2 (Figure 3.4a,) and to produce MTA (Figure 3.4b). However, the 
single mutants are not as active as the wild type PhDph2, as judged by the amount of 
MTA formed in the reaction (Figure 3.4b). Unlike the single mutants, the double 
mutant of PhDph2 (C59A/C287A) has no activity (Figure 3.7a, lanes 11 and 14), 
consistent with the finding that the double mutant cannot bind a [4Fe-4S] cluster.  
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Figure 3.4. Activity assay of PhDph2 single mutants monitored by autoradiography 
and HPLC. a. 14C- labeling of PhEF2 by PhDph2 wild type and three single mutants. 
The reactions contain PhEF2, PhDph2 (WT or mutants), SAM, and dithionite. Left 
panel shows the Coomassie Blue-stained gel and right panel shows the 
autoradiography. b. Reaction product methylthioadenosine (MTA) formation was 
detected by HPLC. SAM was eluted at 2 min and MTA was eluted at 21.5 min.  
 
Expression and purification of PhDph2 heterodimer  
To obtain a PhDph2 heterodimer with only one subunit capable of binding a 
[4Fe-4S] cluster to investigate the reaction mechanism, we co-expressed PhDph2 wild 
type with a His6 tag (WT-His6) and the C59A/C287A double mutant with a GST tag 
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(DM-GST). The proteins were first purified by a Ni affinity purification to give a 
mixture of PhDph2 WT-His6: WT-His6 homodimer and WT-His6: DM-GST 
heterodimer. The mixture was then subjected to a glutathione affinity purification to 
give the DM-GST: WT-His6 heterodimer (Figure 3.5). The homodimers WT-His6: 
WT-His6 and DM-GST:DM-GST can be obtained by further purifying the flow 
through from the two affinity purification steps(Figure 3.5a). The homodimer and 
heterodimer after such purifications were checked by SDS-PAGE as shown in Figure 
3.5b, which demonstrates that our tandem purification strategy works as outlined in 
Figure 3.5a. 
 
 
Figure 3.5. Tandem purification to get different PhDph2 dimers. a. Diagram showing 
the tandem purification strategy to get different PhDph2 dimers; b. Tandem 
purification of PhDph2 dimers: left, elutions from Ni-NTA purification by using 
different concentrations of imidazole solutions to get PhDph2 (WT-His6) and PhDph2 
(DM-GST:WT-His6) mixture; Right, purification of PhDph2 (DM-GST), PhDph2 
(DM-GST:WT-His6), and PhDph2 (WT-His6). PhDph2 (WT-His6). c. Purified 
PhDph2 dimers. The PhDph2 (WT-His6) shown here was further purified by heating at 
95 °C.  
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PhDph2 heterodimer is stable.  
In order to use the PhDph2 heterodimer to study the reaction mechanism, we 
have to make sure that the heterodimer is stable. If it is not stable and subunits can 
dissociate and reassociate, then homodimers of WT and double mutant will form in 
the reaction and complicate the data analysis.  The homodimers WT-His6: WT-His6 
and DM-GST: DM-GST were first mixed to allow subunits exchange, if there was 
any. The mixture was then incubated with Ni-NTA resin. If subunits exchange occurs, 
the heterodimer DM-GST: WT-His6 will form, which will bind to the Ni-resin, leading 
to the retaining of DM-GST on the resin. If subunits exchange did not occur, only the 
WT-His6 will be retained on the Ni-resin. Proteins retained on Ni-resin can then be 
eluted with imidazole and analyzed by SDS-PAGE. The detection of the GST-tagged 
protein in the imidazole elutions on SDS-PAGE would indicate that subunits exchange 
has occurred.  Based on this analysis, PhDph2 WT-His6 (~ 34 kDa per monomer, 
Figure 3.5c, lane 2) and DM-GST (about 60 kDa per monomer, Figure 3.5c, lane 4) 
can indeed undergo subunit exchange when mixed together, because DM-GST was 
detected on SDS-PAGE in the imidazole elutions (Figure 3.6b, lane 2 and 3). By the 
same analysis, if subunit exchange occurs to the PhDph2 heterodimer (WT-His6: DM-
GST), then the homodimer with GST-tagged double mutant will form which cannot be 
retained on the Ni-resin.  When we carried out the experiment with the heterodimer, 
no DM-GST was detected in the flow through on SDS-PAGE (Figure 3.6b, lane 5) 
and both WT-His6 and DM-GST were found in the elutions from Ni-resin (Figure 
3.6b, lane 6). As a control, when we used the homodimer of DM-GST, we can readily 
detect it in the flow through (Figure 3.6a, lane 1). Taken together, we found that the 
homodimers are not stable, but the heterodimer is stable. 
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Figure 3.6. Stability of PhDph2 homodimer and PhDph2 (DM-GST:WT-His6) 
heterodimer. a. PhDph2 (DM-GST) cannot bind to Ni resin, it was found in the flow 
through of Ni-affinty purification but not in the elutions. b. Stability test. Left of the 
protein marker: PhDph2 (WT-His6) and (DM-GST) were mixed, incubated for 90 min, 
and then purified with Ni-resin. PhDph2 (DM-GST) was found in flow through; 
PhDph2 (DM-GST:WT-His6) and PhDph2 (WT-His6) were eluted from Ni resin by 
150 mM and 200 mM imidazole; Right of the protein marker: PhDph2 (DM-
GST:WT-His6) heterodimer from tandem purification was incubated with Ni-resin 
then eluted with 150 mM imidazole. No homodimer was found in the flow through.  
 
The PhDph2 heterodimer is active.  
To test whether the first step of diphthamide biosynthesis requires the PhDph2 
dimer to have two [4Fe-4S] clusters or only one is sufficient, we set up reactions either 
with the PhDph2 heterodimer (WT-His6:DM-GST) or with the WT homodimer. The 
heterodimer, like wild type PhDph2, can catalyze the transfer of 3-amino-3-
carboxylpropyl from SAM to EF2, as indicated by the 14C-labeling experiment (Figure 
3.7a). Similar results were obtained when we monitored the formation of MTA, by 
HPLC (Figure 3.7c blue and brown line). In contrast, the DM-GST homodimer has no 
activity (Figure 3.7c lane4, pink line).  In order to make sure that the reaction rates  
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Figure 3.7. Activity assay of PhDph2 heterodimer. a. Time course of reactions 
catalyzed by PhDph2 wild type (WT-His6) homodimer, PhDph2 double mutant and 
wild type heterodimer (DM-GST:WT-His6) and PhDph2 double mutant  (DM-GST) 
homodimer by using 14C-labeled SAM. The upper panel shows the Coomassie blue-
stained gel and the lower panel shows the autoradiography. b. Plot of the intensity of 
labelled PhEF2 (shown on the autoradiography in a) versus time. c. The formation of 
MTA catalyzed by different PhDph2 dimers was detected by HPLC. 
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catalyzed by heterodimer and WT homodimer was the same, we monitored the 
reaction time.  The results shown in Figure 3.7a and Figure 3.7b indicate that the rate 
catalyzed by heterodimer was essentially the same as that catalyzed by wild type. 
These results suggest that only one [4Fe-4S] cluster per PhDph2 dimer is required for 
the reaction, which is consistent with the mechanism shown in Figure 3.2a.  
PhEF2 (shown on the autoradiography in a) versus time. c. The formation of MTA 
catalyzed by different PhDph2 dimers was detected by HPLC.  
 
No aminobutyric acid is formed when excess PhEF2 is present.  
Our previous results showed that in the absence of PhEF2, PhDph2 can 
catalyze the cleavage of SAM to form 2-aminobutyric acid (ABA) (17). However, 
whether ABA is formed when excess PhEF2 is present will depend on the detailed 
reaction mechanism. In the mechanism shown in Figure 2a, no ABA will form in the 
presence of excess PhEF2. In contrast, in the mechanism shown in Figure 2b, ABA 
will form in the presence of excess PhEF2. To further differentiate the two 
mechanisms shown in Figure 2, we detected the formation of ABA by LCMS after 
dansylation. In the absence of PhEF2, ABA was formed, consistent with our previous 
results (17) With excess PhEF2, no ABA was detected (the level is the same as the 
negative control, Figure 3.8). The data provide further support for the mechanism 
shown in Figure 3.2a.  
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Figure 3.8. Detection of dansylated 2-aminobutyric acid (ABA) by LCMS. Left panel 
shows the MS traces and right panel shows the LC traces. Components used in 
different reactions were labeled in the figure. ABA was only formed in the reaction 
with PhDph2 but without PhEF2.   
 
Discussion 
Our previous work showed that PhDph2 forms a homodimer (17). Each 
subunit consists of three domains. Three cysteine residues (Cysteine59, Cysteine163 
and Cysteine287), each from a different domain, are clustered in the center of each 
PhDph2 subunit to bind a [4Fe-4S] cluster. The three cysteine residues are conserved 
in eukaryotic Dph1 proteins but only two of the three cysteine residues are conserved 
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in eukaryotic Dph2 proteins. It is intriguing whether all three cysteine residues in 
archaeal PhDph2 are required for enzyme activity and whether the PhDph2 dimer 
requires one or both subunits to contain a [4Fe-4S] cluster for activity.  
To test whether all the three conserved cysteine residues are required for the 
activity of PhDph2, we performed site directed mutagenesis to change the three 
cysteine residues to alanine. We then studied how such mutations affect the enzyme 
activity by monitoring the reaction products (the modified PhEF2 and MTA). The 
results showed that mutating one of the three cysteine residues did not affect the 
activity much (Figure 4). Thus, two conserved cysteine residues are sufficient for the 
activity of PhDph2. The spectroscopic data also suggest that the single cysteine 
mutants can still bind a [4Fe-4S] cluster (Figure 3). However, after changing two of 
the cystein residues to alanine (C59A/C287A), PhDph2 cannot bind to the Fe-S cluster 
and is inactive. 
To gain further insights into the detailed reaction mechanism of PhDph2, we 
examined the activity of a heterodimer of PhDph2 consisting of one wild type subunit 
and one C59A/C287A double mutant. In this heterodimer, the wild type subunit can 
bind a [4Fe-4S] cluster while the double mutant cannot. Our stability measurement 
suggests that the heterodimer is more stable than the homodimers. The reason for this 
stability is not clear. It is possible that the PhDph2 dimer with one [4Fe-4S] cluster is 
thermodynamically more stable. Alternatively, the GST tag on the double mutant may 
somehow disfavor the formation of the double mutant homodimer. Under the 
experimental conditions tested, the heterodimer is as active as the wild type PhDph2 
homodimer (Figure 7). The results support the mechanism shown in Figure 2a and 
indicate that only one [4Fe-4S] cluster per PhDph2 dimer is sufficient for the reaction. 
This conclusion is consistent with our previous structure of PhDph2, in which only 
one [4Fe-4S] is found to be present in the dimer (17). Furthermore, we demonstrated 
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that when excess PhEF2 was present, no ABA was formed in the reaction (Figure 8). 
This result indicates that the ACP radical generated does not undergo hydrogen 
abstraction in the presence of PhEF2 and thus the addition to the imidazole ring is 
more likely, which further supports the mechanism shown in Figure 2a. It is 
interesting to note that in classical Radical SAM enzymes, the deoxyadenosyl radical 
generated always does hydrogen abstraction to carry out the enzymatic reaction.(21, 
22) In contrast, in PhDph2, all our evidences suggest that the 3-amino-3-
carboxypropyl radical should undergo an addition reaction instead of hydrogen 
abstraction. Thus, the non-classical Radical SAM enzyme PhDph2 differ not only in 
the radical species derived from SAM, (17), 21 but also in the downstream chemistry 
that the radical undergoes.  
 
Experimental 
Cloning, expression, and purification of PhDph2, PhDph2 mutants and PhEF2.  
Cloning, protein expression and purification of PhDph2 and PhEF2 were 
reported(17). PhDph2 site directed mutants (C59A, C163A, C287A and 
C59A/C287A) were carried out by overlap-extension polymerase chain reaction 
(PCR) (23) with AccuPrime Pfx DNA polymerase (Invitrogen). The constructed 
mutant genes were inserted into pENTRTM/TEV/D-TOPO® entry vector (Invitrogen). 
The amplified plasmid was purified using QIAprep® Spin Miniprep Kit (QIAGEN) 
and its sequence was confirmed by DNA sequencing (performed by Cornell 
University Life Sciences Core Laboratories Center). PhDph2 C59A and C287A single 
mutants were recombined with destination vector pDESTF1 to create expression 
clones with an N-terminal His6 tag. The double mutant was recombined with 
pDEST15 with an N-terminal GST tag. A different cloning method was used for 
PhDph2 C163A. The PCR product was digested by EcoRI and SalI and the mutant 
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gene was ligated into pET28a vector by T4 DNA ligase. 
Construction and tandem purification of PhDph2 heterodimer.  
The plasmids containing PhDph2 wild type with His6 tag (WT-His6) in 
pCDFduet vector and PhDph2 C59A/C287A double mutant with GST tag (DM-GST) 
in pDEST15 vector were co-transformed into the E. coli expression strain BL21(DE3) 
with pRARE2. The cells were grown in LB media with 100 g/ml ampic　 illin, 25 
g/ml chloramphenicol, and 50 g/ml streptomycin at 37　 °C and induced at OD600 of 
0.8 with 0.1 mM isopropyl-β-D-thiogalactopyranoside (IPTG). The induced cells were 
incubated in a shaker (New Brunswick Scientific Excella E25) at 37°C and 200 rpm 
for 3 h. Cells were harvested by centrifugation at 6,371 g (Beckman Coulter Avanti J-
E) and 4°C for 10 min. Cell pellets were transferred into an anaerobic chamber (Coy 
Laboratory Products) and pellets from 2L of LB culture were re-suspended in 30 ml 
lysis buffer (500 mM NaCl, 10 mM MgCl2, 5 mM imidazole, and 20 mM Tris-HCl at 
pH 8.0) with 0.01% lysozyme, which were stored and de-oxygenated in the anaerobic 
chamber. The resuspended cells were sealed in a polypropylene tube and taken out for 
freezing with liquid nitrogen and then thawed at 26°C in the anaerobic chamber to lyse 
the cells. The sealed tube containing the cell lysis were taken out of the anaerobic 
chamber and centrigued at 48,400 g (Beckman Coulter Avanti J-E) for 30 min and 
then taken back into the anaerobic chamber for further processing. The supernatant 
was incubated for 1 hour with 1.2 ml Ni-NTA resin (Qiagen) pre-washed with water 
and equilibrated with the lysis buffer. The resin was then loaded onto a polypropylene 
column and washed with 20 ml lysis buffer. PhDph2 heterodimer (WT-His6:DM-GST) 
and wild type homodimer (WT-His6:WT-His6) were eluted from the column with 
elution buffers (100 mM, 150 mM and 200 mM imidazole in the lysis buffer, 1.5 ml 
each). The protein was buffer-exchanged to GST bind/wash buffer (43 mM Na2HPO4, 
14.7 mM KH2PO4, 1.37 M NaCl and 27 mM KCl) using a Bio-Rad 10–DG desalting 
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column. The heterodimer was further purified by incubating with GST binding resin ( 
Novagen) for 2 hours at 26°C in the anaerobic chamber. The resin was then loaded 
onto a polypropylene column and washed with 20 ml GST bind/wash buffer. PhDph2 
heterodimer was eluted from the column with 4 ml GST elution buffer (10 mM 
glutathione in 50mM Tris-HCl buffer, pH 8.0). DM-GST in the flow-through from the 
Ni resin purification was purified with GST binding resin. WT-His6 from the flow 
through of the GST purification was incubated with Ni-Resin to concentrated and then 
further purified by heating at 90 °C for 5 min. 
PhDph2 dimer stability test.  
PhDph2 homodimers (DM-GST: DM-GST and WT-His6: WT-His6) were 
mixed in 1:1 ratio and incubated at 26°C for 1.5 hours in an anaerobic chamber (Coy 
Laboratory Products). The mixture was then incubated with Ni-NTA resin for 1 hour 
at 26°C and loaded onto a polypropylene column, washed with lysis buffer (20 mM 
Tris-HCl with 500 mM NaCl, 10 mM MgCl2 and 5 mM imidazole, pH 8.0), and eluted 
with 100 mM, 150 mM and 200 mM imidazole in the lysis buffer. Both flow through 
and elution fractions were checked by SDS-PAGE. PhDph2 (DM-GST: WT-His6) 
from the tandem purification was incubated at both 26 and 37°C for 1.5 hours before 
incubating with Ni-resin and elution from Ni-resin. 
UV-Vis spectroscopy of PhDph2 mutants.  
Samples of PhDph2 and mutants (50 µM), with and without dithionite, were 
prepared anaerobically in 150 mM NaCl solution and 200 mM Tris-HCl at pH 7.4. 
The sample treated with dithionite was allowed to incubate for 30 min after adding the 
reducing reagent at a final concentration of 0.5 mM. The samples were sealed in a 
quartz cell (100 µl each) before taking out from the anaerobic chamber. UV-Vis 
spectra were obtained on a Cary 50 Bio UV-Visible spectrophotometer (Varian), 
scanning from 200 nm to 800 nm. The baseline was corrected with the buffer used to 
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prepare the samples. 
EPR spectroscopy of PhDph2 mutants 
ESR spectra were recorded on a Bruker EMX (BRUKER, Billerica, MA) 
spectrometer at a frequency of 9.24 GHz under standard conditions in 4 mm ID quartz 
tubes. A liquid helium cryostat, ESR-10 (Oxford Instruments Ltd, England) was used 
to stabilize the temperature in the range of 4-50K. Spectra shown in Figure 2 d are 
recorded with a modulation amplitude of 8G and microwave power 0.63 mW. 
Activity assay of PhDph2 wild type and mutants by autoradiography and HPLC 
The reaction components, 12 µM PhEF2, 40 µM PhDph2 mutants (C59A and 
C287A), and 10 mM dithionite, were mixed in 150 mM NaCl, 1 mM DTT, and 200 
mM Tris-HCl at pH 7.4 to a final volume of 15 µl in the anaerobic chamber under 
strictly anaerobic conditions. The reaction vials were sealed before taking out of the 
anaerobic chamber. Carboxy-14C-SAM (2 µL, final concentration of 27 µM) was 
injected into each reaction vial to initiate the reaction. The reaction mixtures were 
vortexed briefly to mix and incubated at 65°C for 40 min. The reaction was stopped by 
adding loading buffer to the reaction mixture and subsequent heating at 100°C for 10 
min, which was resolved by 12% SDS-PAGE.  The dried gel was exposed to a 
PhosphorImaging screen (GE Healthcare, Piscataway, NJ) and the radioactivity was 
detected using a STORM860 phosphorimager (GE Healthcare, Piscataway, NJ). 
The reactions of PhEF2 and PhDph2 single mutants / double mutant / 
heterodimer  analyzed by HPLC are similar to those of analyzed by radio labeling 
except that they were scaled up to a final volume of 60 µl and a normal SAM instead 
of a 14C SAM was used. The reaction mixture was quenched by 5% TFA   and   
centrifuged to separate the precipitated proteins and the supernatant. The supernatant 
was analyzed by HPLC (Shimadzu) on a C18 column (HαSprite) monitored at 260 nm 
absorbance, using a linear gradient from 0 to 40% buffer B in 20 min at a flow rate of 
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0.3 ml min-1 (buffer A: 50 mM ammonium acetate, pH 5.4; buffer B, 50% (v/v) 
methanol/water). 
Time course reaction of PhDph2 wild type and heterodimer  
PhDph2 wild type (10 µM) / heterodimer (20 µM) / double mutants (10 µM) 
was incubated with PhEF2 (25 µM), carboxy-14C-SAM (20 µM) and dithionite (5 
mM) in a vial sealed with a rubber cap at 37°C. The amount of iron sulfur cluster 
contained in wild type and heterodimer are the same (based on the absorbance at 400 
nm). Eight microliter reaction mixture was taken out at 2 min, 4 min, 6 min, 12 min, 
20 min, and 50 min and the reaction was stopped by freezing at -20°C. Reaction with 
PhDph2 double mutants was monitored at 20 min and 50 min. Reaction mixtures at 
different time slots were mixed with gel loading dye and subsequent heated at 100°C 
for 10 min, then resolved by 12% SDS-PAGE.  The dried gel was exposed to a 
PhosphorImaging screen (GE Healthcare, Piscataway, NJ) and the radioactivity was 
detected using a STORM860 phosphorimager (GE Healthcare, Piscataway, NJ). The 
signal was quantified by Image Quant TL (Amersham Biosciences).  The intensity of 
14C-labeled PhEF2 was plotted vs time.  
Dansylation of the reaction products and detection by LC-MS. 
 To differentiate the two possible mechanisms, reactions catalyzed by PhDph2 
with excess of PhEF2 or without PhEF2 were set up anaerobically. The reaction 
products were characterized by dansylation reaction which was monitored by LC-MS 
as previously described (17). 
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CHAPTER 4 
 
RECONSTITUTION OF DIPHTHINE SYNTHASE ACTIVITY IN VITRO∗ 
Abstract 
Diphthamide, the target of diphtheria toxin, is a unique posttranslational 
modification on eukaryotic and archaeal translation elongation factor 2 (EF2). 
Although diphthamide modification was discovered three decades ago, in vitro 
reconstitution of diphthamide biosynthesis using purified proteins has not been 
reported. The proposed biosynthesis pathway of diphthamide involves three steps. Our 
laboratory has recently showed that in Pyrococcus horikoshii (P. horikoshii), the first 
step uses an [4Fe-4S] enzyme PhDph2 to generate a 3-amino-3-carboxypropyl radical 
from S-adenosyl-L-methionine (SAM) to form a C-C bond.  The second step is the 
trimethylation of an amino group to form the diphthine intermediate. This step is 
catalyzed by a methyltransferase called diphthine synthase or Dph5. In this chapter, I 
present the in vitro reconstitution of the second step using P. horikoshii Dph5 
(PhDph5). Our results demonstrate that PhDph5 is sufficient to catalyze the mono-, di-
, and trimethylation of P. horikoshii EF2 (PhEF2). Interestingly, the trimethylated 
product from PhDph5-catalyzed reaction can easily eliminate the trimethylamino 
group. The potential implication of this unexpected finding on the diphthamide 
biosynthesis pathway is discussed. 
Introduction 
Diphthamide, found in both eukaryotes and archaea(1-3), is a unique 
posttranslationally modified histidine residue on translational elongation factor 2 
(EF2), a GTPase required for ribosomal protein synthesis (4). The histidine residues 
                                                 
∗ Reproduced with permission from Zhu, X et al. Biochemistry, 2010, 49 (44), pp 9649–9657 
Copyright © 2010 American Chemical Society 
 
 105 
that are modified are His699 in yeast EF2, His715 in mammalian EF2, and His600 in 
Pyrococcus horikoshii EF2. Diphthamide is the target of diphtheria toxin(5), which 
ADP-ribosylates diphthamide and inhibits protein synthesis, leading to host cell 
death(6). It has been indicated that diphthamide may prevent the -1 frame shift during 
protein synthesis(7). However, the physiological function and biosynthesis of the 
modification are still not completely understood(8), despite of the fact that the 
modification has been known for over three decades. Diphthamide modification has 
been proposed to involve three steps (Figure 4.1)(9). 
 
 
Figure 4.1. Proposed diphthamide biosynthesis pathway. The diphthamide residue is 
the target of bacterial ADP-ribosyltransferases, such as diphtheria toxin and 
Pseudomonas exotoxin A. The ADP-ribosylation of diphthamide by these toxins leads 
to inhibition of protein synthesis in the eukaryotic host cells. 
 
 The first step is the transfer of the 3-amino-3-carboxypropyl group from S-adenosyl-
L-methionine (SAM) to the C-2 position of the imidazole ring of the target histidine 
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residue in EF2. The second step is the trimethylation of the amino group to form an 
intermediate called diphthine. The last step is the ATP-dependent amidation of the 
carboxyl group of diphthine. Genetic studies have identified five proteins in 
eukaryotes required for the biosynthesis of diphthamide, Dph1, Dph2, Dph3, Dph4, 
and Dph5. Dph1-4 are known to be required for the first step (6, 10-15), whereas 
Dph5 (also called diphthine synthase) is known to be required for the second step(16). 
The enzyme that catalyzes the last step has not been identified yet. Diphthamide is 
also found in archaea. However, among the five eukaryotic proteins required for 
diphthamide biosynthesis, only two orthologs can be found in archaea by BLAST 
search. One of them, Dph2, is homologous to eukaryotic Dph1 and Dph2 (Dph1 and 
Dph2 are homologous to each other), and the other one is the diphthine synthase, 
Dph5. 
Although five genes are known to be required for the first two steps of 
diphthamide biosynthesis, it is not clear whether these genes are sufficient. In fact, 
another gene, WDR85 (17), was recently identified to be required for the first step of 
diphthamide biosynthesis in eukaryotes, further demonstrating the complexity of 
diphthamide biosynthesis. The same can be said about the second step: one can 
similarly ask whether Dph5 alone is sufficient to catalyze the trimethylation or 
additional proteins are needed. Therefore, to fully understand diphthamide 
biosynthesis, it is important to reconstitute the biosynthesis in vitro using purified 
proteins. Recently, we have successfully reconstituted the first step of diphthamide 
biosynthesis using the Pyrococcus horikoshii Dph2 (PhDph2) and EF2 (PhEF2)(18). 
We found that PhDph2 forms a homodimer and can bind a [4Fe-4S] cluster in each 
monomer with three conserved cysteine residues. PhDph2 is similar to the radical 
SAM superfamily(19) in that both contain [4Fe-4S] clusters and are SAM-dependent. 
However, PhDph2 does not contain the CXXCXXXC motif(20) that is found in most 
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radical SAM enzymes. Furthermore, we showed that PhDph2 likely generates a 3-
amino-3-carboxypropyl radical in the first step of diphthamide biosynthesis, instead of 
a 5’-adeoxyadenosyl radical. The successful reconstitution of the first step of 
diphthamide biosynthesis sets the stage for us to investigate the second step of 
diphthamide biosynthesis by providing the substrate to test whether PhDph5 is 
sufficient for the trimethylation step in vitro. Herein we report the reconstitution of 
PhDph5 activity. Our data suggest that PhDph5 is sufficient for the second step of 
diphthamide biosynthesis and that it catalyzes the trimethylation in a highly processive 
manner. Interestingly, we found that after the trimethylation step, the resulting 
diphthine product is not stable and can easily eliminate the trimethylamino group in a 
reaction similar to Hofmann elimination or Cope elimination(21).  
Results 
Initial PhDph5 activity assay with 14C-labeled SAM gave no labeling.  
PhEF2 (83 kDa), PhDph2 (38 kDa) and PhDph5 (30 kDa) were expressed in E. 
coli and purified as described in the Experimental Procedures. Their purity and sizes 
were checked by SDS-PAGE (Figure 4.2).  
 
Figure 4.2. Purified PhEF2 (83 kDa), PhDph2 (38 kDa) and PhDph5 (30 kDa). 
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By incubating PhEF2 with PhDph2 and SAM under anaerobic conditions, we 
first obtained PhEF2 with the 3-amino-3-carboxypropyl (ACP) group attached to 
His600.  
 
Figure 4.3. Monitoring PhDph2-catalyzed PhEF2 modification using MALDI-MS. a, 
unmodified PhEF2 peptide residue with m/z 1545.8; b, PhEF2 modified with 3-amino-
3-carboxypropyl (ACP) group. Two peaks showed in the spectrum: unmodified 
PhEF2 peptide with m/z 1545.8; ACP-modified PhEF2 peptide with m/z 1646.8. 
 
The reaction was monitored by MALDI-MS (Figure 4.3). The observed masses of the 
peptide fragments in Figure 4.3 are consistent with the calculated masses of estimated 
peptide fragments as shown in Table 4.1. The peptide fragment containing the His600 
residue (LLDAQVHEDNVHR) in unmodified PhEF2 has an m/z of 1,545.80 (MH+, 
calculated 1545.78, Figure 4.3a). This peak was almost gone after reaction with 
PhDph2 and a new peak with an m/z of 1,646.84 appeared (Figure 4.3b), which  
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corresponds to the product of the PhDph2-catalyzed reaction with the ACP-modified 
histidine residue (MH+, calculated 1646.83). 
Table 4.1. Calculated masses of peptide fragments are consistent with those observed 
in PhEF2 MALDI-MS spectra in Figure 4.3 
 
To test the activity of the purified PhDph5, the first step reaction mixtures 
were buffer exchanged to PhDph5 reaction buffer. PhDPh5 and excess methyl-14C 
SAM were then added to initiate the trimethylation reaction. To our surprise, no 
labeling on PhEF2 was found (data not shown) by autoradiography. We reasoned that 
additional proteins or other molecules other than PhDph5 may be needed to 
reconstitute the second step, since all the reported Dph5 activity assay were performed 
in vivo or by using crude cell lysate (16, 23). However, it is also possible that PhDph5 
alone can catalyze the second step, but our reaction conditions need to be optimized to 
get the reaction to work. 
Detection of SAH shows SAM-degrading activity catalyzed by PhDph5. 
 In the process to find out why no 14C-methyl group can be transferred to 
PhEF2, we tried other methods to detect the product of the reaction catalyzed by 
PhDph5. One product of methyl transfer reaction by SAM-dependent 
methyltransferase is S-adenosylhomocysteine (SAH), which can be used to indicate 
whether the methyltransfer reaction occurred or not. We monitored the SAH formation 
with HPLC (Figure 4.4). Standard SAH was eluted at 10 min, as shown in Figure 4.4 
(dark blue line). In the reaction without PhDph5, no SAH was detected (Figure 4.4, 
black line). In contrast, when PhDph5 was present, the SAH peak increased (Figure 
peptide fragment calculated m/z observed m/z
LLDAQVHEDNVHR 1545.78 1545.8025
QLVLDFDEQEQAR 1590.78 1590.7964
VPNELAQQIIRQIR 1677.97 1678.8427
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4.4, pink line) even when no additional SAM was added (some left-over SAM 
molecules were present from the first step PhDph2-catalyzed reaction). With 
increasing concentrations of SAM, the SAH peak increased first then remained 
unchanged (Figure 4.4, brown and green lines). Taken together, the data suggest that 
PhDph5 is active since it can remove the methyl group from SAM in the presence of 
the PhEF2 substrate.   
 
 
Figure 4.4.  HPLC analysis of the reaction product showed that PhDph5 catalyzes the 
formation of SAH. Absorption was monitored at 260 nm. The description of each 
overlaid trace is provided on the right, and the identities of major peaks were 
indicated. In the reaction marked by *, no extra SAM was added. However, some 
SAM (less than 10 M) was left from the PhDph2　 -catalyzed reaction to make ACP-
modified PhEF2 and led to the formation of SAH when PhDph5 was added.  
 
MALDI-MS/MS of PhEF2 revealed an elimination reaction that occurred to 
diphthine.  
The detection of the SAM-cleavage activity suggests that PhDph5 is active 
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under the conditions used, although it remained unclear where the methyl group of 
SAM ends up. To find out whether the methyl group is transferred to PhEF2, we 
decided to use MALD-MS to monitor the mass of PhEF2. After incubating PhEF2 
with PhDph5 and SAM, the reaction mixture was resolved by SDS-PAGE and the 
PhEF2 band was excised, digested, and analyzed by MALDI-MS. We could not see 
any peaks for the mono-, di- or tri-methylation products, which is consistent with our 
previous results obtained with methyl-14C SAM. However, a new peak with an m/z of 
1629.77 was detected (Figure 4.5b) which was not present in the control, the ACP-
modified PhEF2 not subjected to the Dph5 reaction (Figure4.5a). Since the diphthine-
containing peptide has a calculated m/z of 1688.87 (M+) and a trimethylamino group 
has an m/z of 59.1, the peak of 1629.77 corresponds to the loss of the trimethylamino 
group from diphthine, the trimethylated product. The peptide fragment containing the 
elimination product has a calculated m/z of 1629.80 (MH+). To confirm that the 
trimethylamino group was eliminated and a 3-carboxy-2-propenyl group is formed on 
the histidine residue after elimination (Figure 4.9), we analyzed the 1629.77 peak by 
tandem MS. The mass difference between Y1 and Y2 ions is 221, which is consistent 
with the presence of a 3-carboxy-2-propenyl on the histidine residue (Figure 4.6). This 
result suggested that PhDph5 can catalyze the trimethylation reaction but the diphthine 
product cannot be detected due to the elimination of the trimethylamino group. 
P. horikoshii grows optimally at 98oC. For the in vitro reconstitution, we normally 
carry out the reaction at 65oC, which we found to be optimal for the activity of 
PhDph2. One concern was that the high temperature may contribute to the elimination. 
Thus to minimize the elimination reaction, we later carried out the Dph5-catalyzed 
reactions at 37oC. Similarly, when analyzing the reaction by SDS-PAGE, we did not 
heat the sample to denature the protein. However, even under these milder conditions, 
the elimination always occurred based on both MS and the 14C-labeling experiments 
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(data not shown). The other concern is that the elimination could occur during 
MALDI-MS from absorbing the energy of laser. This is also unlikely because the 
elimination also happened in the 14C-labeling experiments in which the reaction was 
deteted by autoradiography. These observations suggest the elimination occurs readily 
under the reactions conditions. 
 
 
 
Figure 4.5. The MALDI-MS analysis of PhEF2 in PhDph5-catalyzed reaction. (a) 
PhEF2 from control reaction with PhDph5; (b) PhEF2 after PhDph5-catalyzed 
reaction. The peak with m/z 1545.8 corresponds to unmodifed PhEF2 peptide, 1646.8 
corresponds to ACP-modified PhEF2 peptide, and 1629.8 corresponds to the 
elimination product. 
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Figure 4.6. MS/MS of precursor 1629.81, which is from the MALDI spectrum of EF2 
modified by PhDph5. The table lists calculated Y ions. Observed Y ions in the 
spectrum are colored in red. 
 
Decreasing SAM concentrations allows the detection of 14C-labeling on PhEF2. 
Although the above result suggested that PhDph5 can catalyze the trimethylation 
reaction, the actual methyltranfer to PhEF2 still need to be proven. The elimination of 
the trimethylamino group is similar to the Hofmann elimination reaction that can 
occur to quaternary ammonium hydroxide salts or the Cope elimination reaction that 
can happen to tertiary amine oxides(21). In Hofmann or Cope elimination, a 
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quaternary ammonium functional group is required for the elimination to occur. Thus, 
we reasoned that if we can stop the PhDph5-catalyzed reaction at mono- and di- 
 
Figure 4.7. PhDph5-catalyzed PhEF2 methylation monitored by methyl-14C SAM. 
The PhDph5 activity assays were set up with 30 µM ACP-modified PhEF2, 60 µM 
PhDph5, and different SAM concentrations (0 µM, 2.5 µM, 5 µM, 10 µM, 20 µM, 30 
µM and 50 µM). The reactions were incubated at 37°C for 30 min. Bottom panel 
shows the Coomassie blue-stained gel; top panel shows the autoradiography. The 
concentration ratios of SAM to PhEF2 were shown at the bottom of the image. 
 
methylation stage, then no elimination reaction will occur and we may be able to 
detect the methyl transfer to PhEF2. Therefore we revisited the labeling experiment 
using different concentrations of methyl-14C SAM, hoping to accumulate the mono- 
and di-methylated PhEF2. After the first modification reaction, the buffer was 
exchanged to the methylation reaction buffer to make sure the amount of leftover 
SAM from the previous step was as little as possible. Different concentrations of 14C-
SAM and PhDph5 were then added to allow the methylation to occur. The reaction 
mixtures were resolved by SDS-PAGE and the labeling was detected by  
autoradiography. When no methyl-14C SAM was added, no labeling was detected 
(Figure 4.7, lane 1). Labeling of PhEF2 was observed when methyl-14C-SAM was 
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added and the labeling increased when the ratio of SAM to PhEF2 increased from 
0.25:3 to 2:3 (Figure 4.7, lane 2 to lane 5). However, the intensity of labeling 
decreased when the ratio reached to 3:3 (Figure 4.7, lane 6). Further increasing the 
ratio of SAM: PhEF2 to 5:3, the labeling disappeared (Figure 4.7, lane 7). These 
results demonstrated that PhDph5 can transfer the methyl group from SAM to PhEF2. 
In addition, the loss of the 14C label on PhEF2 at high concentrations of methyl-14C 
SAM is consistent with the prediction that the trimethylated PhEF2 can undergo the 
elimination reaction while the mono- and dimethylated PhEF2 cannot.  
 
MALDI-MS of reaction products confirmed the formation of mono- and 
dimethylated PhEF2. 
 To confirm the formation of mono- and dimethylated PhEF2, we again relied 
on MALDI-MS. The peptide fragment containing the ACP-modified His600 residue 
after PhDph2-catalyzed modification has an m/z of 1,646.84 (Figure 4.8a). After the 
reaction catalyzed by PhDph5 with 2:3 and 3:3 ratio of SAM: PhEF2, two new peaks 
appeared with m/z of 1,660.83 and 1674.84 (Figure 4.8b and 4.8c), corresponding to 
the masses of PhEF2 with the addition of one (MH+, calculated m/z 1660.84) and two 
methyl groups (MH+, calculated m/z 1674.86). However, when the concentration of 
SAM was higher than that of PhEF2 (5:3), no methylated product was observed 
(Figure 4.8d).  These results firmly established that PhDph5 can catalyze the 
methyltransfer to PhEF2. When one equivalent of SAM is used (Figure 4.8c), the 
major product is the eliminated product after trimethylation of the ACP group while a 
significant amount of unmethylated substrate is still present. This result suggests that 
the trimethylation reaction catalyzed by PhDph5 is highly processive. 
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Figure 4.8. Detecting PhDph5-catalyzed PhEF2 methylation using MALDI-MS.  
Different ratio of PhEF2 to SAM was used to minimize the formation and elimination 
of the trimethylated product. a, PhEF2 modified with 3-amino-3-carboxypropyl (ACP) 
group. ACP-modified PhEF2 peptide has an m/z of 1646.8. b, PhEF2 modified by 
PhDph5 with a SAM to PhEF2 ration of 2:3. Three new peaks with m/z values of 
1629.8; 1660.8; 1674.8 were observed, which correspond to diphthine with the 
trimethylamino group eliminated, monomethylated, and dimethylated intermediates, 
respectively.  c, PhEF2 modified by PhDph5 with a SAM to PhEF2 ratio of 3:3. d, 
PhEF2 modified by PhDph5 with a SAM to PhEF2 ratio of 5:3. Only the elimination 
product with m/z of 1629.8 was observed. 
 117 
 
Discussion 
P. horikoshii Diphthine is not stable in vitro and readily eliminates the 
trimethylamino group.  
Initially, when we used methyl-14C SAM to detect the methylation of PhEF2, 
no methylation was detected. HPLC analysis of the small molecule product showed 
that SAH was formed in the reaction, suggesting that PhDph5 is active. Using 
MALDI-MS, we detected a new product with m/z of 1629.77.  We attributed this peak 
to the product resulting from the elimination of the trimethylamino group from 
diphthine.  The structure of the elimination product was further confirmed by MS/MS. 
The mass difference of the Y2 and Y1 ions is 221, which is consistent with the 
presence of a 3-carboxy-2-propenyl group on His600, the product of diphthine after 
elimination of the trimethylamino group. The elimination reaction is similar to the 
Hofmann elimination reaction or Cope elimination reaction.(21, 24) Given that such 
elimination reaction will require the quaternary ammonium salt, we predicted that the 
mono- and dimethylated PhEF2 should not undergo the elimination product and thus 
should be stable and detectable. Indeed, by lowering the concentration of SAM, mono- 
and dimethylated PhEF2 were detected using methyl-14C-SAM (Figure 4.7) and 
MALDI-MS (Figure 4.8).  This result further confirmed that elimination requires the 
trimethylamino group and that Dph5 can catalyze the trimethylation reaction. There 
are two possible mechanisms for the elimination reaction (Figure 4.9). One 
mechanism uses an external base to attack the proton on the β-carbon (Figure 4.9a) 
and the other mechanism uses the carboxyl group as the intra-molecular base to 
deprotonate the β-carbon (Figure 4.9b). At present, it is not known whether a similar 
elimination reaction also occurs to eukaryotic diphthine. If it does happen to 
eukaryotic diphthine, we would favor the second mechanism for the elimination 
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reaction based on the fact that when the carboxylate is converted to the amide as in 
diphthamide, the trimethylamino group becomes stable given that eukaryotic 
diphthamide has been isolated and structurally determined(2, 25, 26). 
 
 
Figure 4.9. Proposed mechanisms for the elimination reaction of diphthine. 
 
PhDph5 is sufficient for the trimethylation step of diphthamide biosynthesis in vitro. 
Genetic studies have shown that PhDph5 is required for the trimethylation step of 
diphthamide biosynthesis. However, whether PhDph5 is sufficient for the 
trimethylation step was not clear(11). Our data presented above demonstrated that 
PhDph5 is sufficient to catalyze the trimethylation step. Mono- and dimethylated 
PhEF2 was detected by MALDI-MS, while the trimethylated product cannot be 
detected due to the facile elimination of the trimethylamino group. 
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The implication of the instability of diphthine on the diphthamide biosynthesis 
pathway.  
Diphthamide structure was determined using eukaryotic EF2 (2, 25, 26). 
Whether the final structure in archaea is the same or not is not clear. At this point, we 
do not know whether the elimination reaction also occurs physiologically. The 
elimination readily occurs in vitro even though we have taken extra care to avoid 
harsh conditions, such as heat denaturation, to minimize it. However, it is still possible 
that the elimination reaction only occurs in vitro due to the lack of the enzyme for the 
amidation step in the reaction. If diphthamide is the final structure in P. horikoshii, 
given that P. horikoshii diphthine readily eliminate, in order to form the final 
structure, diphthamide, the last amidation step should occur very quickly in P. 
horikoshii cells to avoid the elimination reaction. Alternatively, it is possible that the 
amidation step occurs before the trimethylation step.  
It would be interesting to know whether a similar elimination reaction also 
occurs to eukaryotic diphthine, in vitro and in vivo, and whether the elimination 
reaction affects the function of EF2 in protein synthesis. The genes required for 
diphthamide biosynthesis, dph1-dph5, were identified in yeast and mammalian cells 
by screening for mutants that are resistant to diphtheria toxin, which can ADP-
ribosylate diphthamide and inhibit protein synthesis (6, 10-15). The enzyme for the 
amidation step has not been identified yet using this genetic screening. The 
explanation for the inability to isolate the amidation enzyme is that diphtheria toxin is 
able to ADP-ribosylate both diphthamide and diphthine(11). The elimination of the 
trimethylamino group from diphthine may provide an alternative explanation. If EF2 
loses its normal function in protein synthesis after the elimination of the 
trimethylamino group from diphthine, then the disruption of the gene required for the 
amidation step would lead to the accumulation of diphthine, which will eliminate and 
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stop protein synthesis, giving a lethal phenotype. The lethality of disrupting the gene 
may explain why it has not been identified in the genetic screen. This hypothesis, if 
correct, may help the identification of the gene required for the amidation step in 
eukaryotes. 
 
Experimental 
Cloning, expression, and purification of PhDph2, PhDph5, and PhEF2. The 
cloning, expression, and purification of PhDph2 and PhEF2 were reported(22). 
PhDph5 was amplified by PCR from P. horikoshii genomic DNA (ATCC® 700860D-
5TM) with AccuPrime Pfx DNA polymerase (Invitrogen) and the primers 
(AGTCAGCATATGATGGTTTTGTACTTTATTGGATTG 
&AGTCAGCTCGAGTTAAACATTAACCC TTAATATCTC). Amplified PhDph5 
was digested by NdeI and XhoI (New England BioLabs) and then ligated into the 
pET-28a (+) vector by T4 DNA ligase (Invitrogen). The recombinant plasmid was 
transformed to TOP10 competent cells (Invitrogen), and colonies containing the 
plasmid were selected by colony PCR with EconoTaq® DNA polymerase (Lucigen). 
The amplified plasmid was purified using QIAprep® Spin Miniprep Kit (QIAGEN) 
and its sequence was confirmed by DNA Sequencing (performed by Cornell 
University Life Sciences Core Laboratories Center). 
The plasmid containing PhDph5 was transformed into the E. coli expression 
strain BL21 (DE3) with pRARE2. The cells were grown in LB media with 100 g/ml 　
ampicillin at 37 °C and induced at an OD600 of 0.8 with 0.1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG). The induced cells were incubated in a shaker (New 
Brunswick Scientific Excella E25) at 37 °C and 200 rpm for 3 h. Cells were harvested 
by centrifugation at 6,371 ×g (Beckman Coulter Avanti J-E) and 4 °C for 10 min. Cell 
pellets from 2L of LB culture were re-suspended in 30 ml lysis buffer (500 mM NaCl, 
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10 mM MgCl2, 5 mM imidazole, and 20 mM Tris-HCl at pH 8.0). Cells were lysed 
using a cell disruptor (EmulsiFlex). Cell debris was removed by centrifugation at 
48,400 ×g (Beckman Coulter Avanti J-E) for 30 min. The supernatant was incubated 
for 1 hour with 1.2 ml Ni-NTA resin (Qiagen) that was pre-washed and equilibrated 
with the lysis buffer. The resin was then loaded onto a polypropylene column and 
washed with 20 ml lysis buffer. PhDph5 was eluted from the column with 1.5 mL 
aliquots of buffers containing 100 mM, 150 mM and 200 mM imidazole in the lysis 
buffer. The protein was buffer-exchanged to 50mM Tris-HCl, pH 8.0, with 50 mM 
NaCl using a Bio-Rad 10–DG desalting column. The protein was further purified by 
heating at 65 °C for 10 min and centrifugation at 39,191 ×g to remove the precipitate. 
Purified PhDph5 was concentrated using an Amicon Ultra-4 centrifugal filter device 
(Millipore).  
Reconstitution of PhDph5 activity in vitro and detection of formation of S-adenosyl-
L- homocystein (SAH) by HPLC.  
The first step of PhEF2 modification was performed in an anaerobic chamber (5% 
Hydrogen, 95% Nitrogen) (Coy Laboratory Products).  PhDph2 (240 µM) was 
incubated with 10 mM dithionite for 10 min first.  PhEF2 (100 µM) and SAM (200 
µM) were added and reaction was incubated at 65 °C for 40 mins. After the first step 
of modification, the reaction mixture was buffer exchanged to PhDph5 reaction buffer 
(23) (100 mM Tris-HCl, pH 8.0, 75 mM NaCl, 50 mM KCl, 1 mM EDTA, 5 mM 
DTT, 5 mM MgCl2, with or without 2 mM ADP, 10 mM creatine phosphate and 80 
pg/ml phosphocreatine kinase) with a 10 kDa Amicon (Millipore) filter and then with 
a Micro Bio-Spin 6 column (BioRad) to get rid of the leftover SAM from the last step 
reaction. The PhDph5 activity assay was carried out with 30 µM modified PhEF2, 60 
µM PhDph5, and SAM at different concentrations (0 µM, 5 µM, 10 µM, 20 µM, 30 
µM and 50 µM) in a total volume of 50 µl and incubating the reaction mixtures at 
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37°C for 30 min. The reactions were stopped by 5% TFA. The precipitated proteins 
were separated from the reaction mixture by centrifugation. The supernatant was 
analyzed by HPLC (Shimadzu) on a C18 column (HαSprite) monitored at 260 nm 
absorbance, using a linear gradient from 0 to 40% buffer B in 20 min at a flow rate of 
0.3 mL/min (buffer A: 50 mM ammonium acetate, pH 5.4; buffer B, 50% (v/v) 
methanol/water).  
Detection of PhEF2 modification by methyl-14C-SAM.  
Enzymatic reactions with methyl-14C SAM followed the similar procedure as 
described above. Reactions were incubated at at 37°C for 30 min. The reaction 
mixtures were resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE, 12% acrylamide gel) without preheating to denature protein. The dried 
gel was exposed to a PhosphorImaging screen (GE Healthcare, Piscataway, NJ) which 
were then scanned by a STORM860 phosphorimager (GE Healthcare, Piscataway, 
NJ).  
Characterization of PhEF2 modification with matrix-assisted laser 
desorption/ionization mass spectrometry (MALDI-MS) and MS/MS.   
PhDph5 activity assay with normal SAM were carried out following the same 
procedure as that used for the activity assay with 14C-labeled SAM. The mixtures were 
separated by SDS-PAGE (12% acrylamide gel) without heating to denature protein.  
The PhEF2 band from the Coomassie blue-stained gel were cut out and washed with 
water, 50% Ambic/acetonitrile and pure acetonitrile. Gel pieces dried in ventilated 
fume hood were digested by trypsin (10µg/mL) overnight in a 30°C incubator (Fisher 
Scientific Inc.) to cleave protein at carboxyl side of lysine or arginine into peptide 
fragments. Digested products were extracted and cleaned up by Ziptip C4 (Millipore). 
MALDI-MS was performed at the Proteomics and Mass Spectrometry Facility of 
Cornell University on an Applied Biosystems 4700 which was operated in positive ion 
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reflector mode (20kV).  The matrix used was alpha-cyano-4-hydroxycinnamic acid at 
3mg/ml in 60%ACN/0.1%TFA with 1mM ammonium phosphate added to suppress 
low m/z matrix adducts.  The instrument was calibrated using calibration mix obtained 
from the instrument manufacturer.  1200 laser shots (80 shots/location, 15 different 
locations and uniform firing pattern) were used to acquire the survey spectrum from 
m/z 700-4000 Da. The zoomed spectrum was from m/z 1500-1700 Da. The peak of 
1629.8 was further analyzed by MS/MS. 
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